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ABSTRACT 
THE EFFECTS OF STREPTOZOTOCIN- INDUCED DIABETES ON RESPONSES TO OPIATES 
AND OTHER CENTRALLY-ACTING PHARMACOLOGIC AGENTS 
Glenn Stuar t Simon, Ph . D . 
Med ical Co llege of  Virginia-Virginia Commonwealth Univer sity , 1 9 7 9 
Maj or Professor: Dr . William L .  Dewey 
Diabetes mellitus af fects  millions o f  people . Although d iab e t ic s  
can lead relatively normal lives , all treatments for the disease  are 
symp tomatic and no t curative . The purpose of  this inves tigation was to 
d etermine whether the sens itivity to opiates and o ther selec ted c entra11y-
acting drugs in animals is altered by s tr ep tozo tocin (STZ) - induced d ia-
betes . A s econd obj ec t ive was to determine which aspec t of the diab e t ic 
syndrome primarily was respons ible for the alter ed s ens itivi ty . Other 
exp er iments were perf ormed in an attemp t to elucidate the mechanism where-
by this altered sens itivity occurred . 
STZ- induced diabetes or d extro s e- induc ed trans ient hyperglycemia d id 
not have a signif icant ef f ec t  on the duration of  hexobarbital-induced 
anes thesia.  Similarly , following 5 days treatment with phenobarbital , the 
duration of hexobarbital-induced anes thesia was reduced equally in bo th 
c ontrol  and STZ-induced d iabetic mic e .  STZ- induc ed diabetes d id no t alter 
the acute oral LDsO of nico tine. 
The antinocicep t ive potency of morphine as d e termined by the tai1-
f lick tes t was signif icantly decr eased (p  < 0 . 05 )  in STZ-induced d iabetic 
mice and mice pretreated with equimo1ar doses of  hyper tonic dextr o s e  or 
f ruc t o s e. STZ- induced diabetic rats and spontaneous ly diabetic mice wer e 
also significantly less s ens i tive to the antinocicep t ive ef f ec t s  of mor-
xix 
phine as quantita ted by the tail-f lick tes t . The ability of morphine to  
inhib i t  phenylquinone-induc ed writhing was attenua ted in STZ-induced dia­
b e tic mic e .  Hypoglyc emic mice wer e  s ignificantly more s ensitive t o  mor­
phine in the tail-f l ick tes t .  Insulin r ever sal of d extros e-induced and 
S TZ- induced diabetic hyperglycemia returned s ensitivity to morphine-induc ed 
antinocic ep tion in the tail-f l ick tes t to  control values . Pretreatment 
with the non-metabolizable sugar 3-0-methylglucos e at a dose equimolar to 
the doses of d extrose and f ruc tose  had no effec t on morphine potency . 
The antinocicep tive potencies of phena zocine and l evorphanol were a l t er ed 
s imilar ly to that of morphine , but the potencies of methadone , propoxyphene 
and meper idine wer e not altered by changes in blood glucose l evels . 
The LDSO of morphine but no t methadone was significantly decrea s ed 
in S TZ-induced diabetic mic e .  The s e  r esult s  conf irm the selec tivity of 
the S TZ-induced diabetes to alter the s ensitivity of morphine and no t 
methadone , and ar e provocative sinc e they show that the lethal ef f e c t  o f  
morphine i s  altered in the oppos ite  d irec tion from the antinocicep tive 
p otency . 
Levels of morphine in the brains o f  STZ-induced diabetic and insulin­
trea ted STZ-induc ed diabetic mice were not significantly differ ent from 
c ontrol mic e .  The dura tions o f  ac tion of morphine in STZ-induced d iabe tic 
and c ontrol mic e were s imilar , al though the level of antinocic ep tion in 
the diabe tic mice was lower at  all time points . 
S TZ-induced diabetes in mice did not alter s erum osmolarity and brain 
water content . Mice receiving various pretr ea tmen ts ( STZ-induced dia­
betes , S TZ-induced d iabetes plu s  insulin , d extros e , fas ting or fas t ing 
plus insulin) wer e subj ected to analyses of their s erum glucos e levels , 
s erum insulin level s , and brain glucos e levels . From these  data only 
xx 
blood glucose levels corr elated ( inver s ely ) with the ant inocicep t iv e  
potency o f  morphine. 
The r esults of these  exper iments led to the hypothes is tha t  the 
hyp er glycemia was the aspect of diabetes principally respons ible for 
s elec t ively affec t ing the po tency of cer tain opiate-like pharmacologic 
agent s .  
INTRODUCTION 
The reasons for s tudying the pharmacologic and toxicologic ef f e c t s  
o f  chemicals in laboratory animals a r e  numerous . They include the d e t er­
mina t ion of  molecular mechanisms of  action , kinetics of  drug ac tion , 
s truc ture-activity relationship s , etc . In many cases, the ul timat e  
rationale for testing the actions o f  a chemical in animals is to  provide 
inf orma tion regarding its potential us efulness  and hazards to man . 
Mo s t  tes ting occur s in normal , healthy animals . Data obtained from 
these exper iments are us eful in predicting the effects  of chemicals in 
humans . Therapeutic agents are des igned to treat a specific dis eas e; 
ther efore , animal models have been developed which can ,  to some ext ent , 
mimic the character is tics  of  the disease seen in man . Thus , ther e is con­
s iderable inf ormation available concerning the effects  of  ant ihyp ert ens ive 
agents on hyper tens ive animals , hypoglycemic agents on diabetic animals , 
etc . , and the eff ec ts of  drugs like antihistamines , barbiturates , nar c o tics 
and non-narcotic analges ic s , etc . on normal , healthy animals . But p eople  
with chronic diseases may take drugs not ordinar ily as sociated with their 
p ar ticular disease s tate . Diabetics can suf f er from insomnia , hyper t en­
s ive individuals may also have allergLes , and p eople wLth asthma can get 
headaches . Anyone may requ ire  surgery , and then suf f er from pos topera tive 
p ain . The obj ectives of this thesis are to determine whether animals  with 
a p ar ticular pathophysiologic condition ( exper imental diabetes)  have an 
alter ed s ensitivity to selected centrally-act ing pharmacologic agents and 
t o  determine the mechanism of this alter ed s ens itivity . 
1 
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Diabetes mellitusl was chosen for several reasons as the pa thophys io-
logic condition to be inves tigated . It  is one of the mos t  common ailment s  
in the United S tates . Over 10 million Amer icans suffer from d iabetes , and 
the number of diabetics is rising by 6% each year (American Diabetes 
As sociation, 1976). The es timated life expec tancy for d iabetic humans is  
shorter than for nond iabetics (Bale and Entmacher, 1977). Diabetes 
melli tus, its causes, symp tomology, treatment, and consequences have been 
the subject of hundred s  of books, symposia and ar ticles . 
When severe diabetes mellitus occurs, many body t issues ( e . g .  muscle ) 
are less able to absorb and utilize glucose from blood . The body reac t s  
a s  i f  it i s  starving, initiating several processes ( e . g .  glycogenolys is, 
gluconeogenes is ) with the net result  being hyperglycemia . Glucose pas s es 
into the ur ine, carrying water with it, caus ing polyuria, dehydration and 
subsequently, polydips ia . The sens ation of s tarvation also lead s to  
polyphagia . Due to glycogenolysis, liver glycogen falls to very low 
levels, and muscle glycogen is lowered, but to a les ser extent . The in-
g es ted and newly formed endogenous glucose contr ibutes to even grea ter 
hyperglycemia, glucosuria, polyuria, etc . ,  creating a vicious cycle . In 
order to maintain the body ' s  energy requirements, tis sue-pro tein breakdown 
o ccur s ( f or gluconeogenes is ) caus ing muscle wasting and increased ur inary 
nitrogen excretion . Body fat depo ts ar e broken down, caus ing produc t ion 
of large quantities of ketone bod ies which canno t be oxid ized by mus cles . 
This causes metabolic ac idos is which can lead to coma and death . Dur ing 
acidos is, the excretion of large amounts of glucose and ketone bodies in 
lDiabetes melli tus, as dis cussed in this dissertation, is def ined as 
a chronic d isorder of carbohydrate metabolism characterized by hypergly­
cemia, result ing from an inad equate produc t ion or ut ilization of insu lin 
(Taber, 1973). 
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the ur ine results in salt loss (Tepperman , 1 9 7 3; Bhagavan , 1 9 7 8 ) . In 
d iabetics where insulin deficiency is the cause  of  these conditions , ad-
minis tration of insulin promptly corrects all the above mentioned meta-
b o lic d is turbances (Bhagavan , 1 9 7 8 ) . However , even with rigid control 
over b lood glucose  levels by insulin management , many of the long-term 
c onsequences of diabetes mellitus (neuropathy , retinopathy , atheros cleros i s , 
microangiopathy and nephropathy) s till occur (Hockaday , 1974) . 
Ther e ar e a number of diff erent animal models that have been d eveloped 
which exhibit to varying degrees many of the charac teristics o f  diab e t es 
melli tus in humans (Meier , 19 60; Renold , 1 9 6 8; Rerup , 197 0; Renold and 
Burr , 1 9 7 0; Stauffacher et al . , 1 9 7 1; Renold et  al . , 1 9 7 1; Renold et  al . , 
1 972 ; Camero� et al . , 197 2; Renold et al . , 1974; Karl , 1 9 7 5; Herb erg and 
Co leman , 1977) . These models may be categor ized by the mechanism in which 
the d iabe tes-like syndrome is induc ed 2 . For example: 
A .  Virally- induced Diabetes . In this model ( Craighead , 197 5 )  the 
M var iant of encephalomyocarditis virus is inj ec ted s . c .  into mice . Virus -
exposed mic e display hyperglycemia , b e ta c ell degranulation and des truc-
t ion, and hypoinsulinemia . Suscep tab ility to the virus varies wi th the 
s train of mouse used . There is limited epidemio logic evidence f or a viral 
link in the etiology of human diabetes mellitus (Maugh, 1975, 1979). 
B .  Immunologically- induced Diabetes . In this model , animals (usually 
guinea pigs) are sens itized to insulin . Their antibodies to insulin are 
2Use of  the terms "j uvenile-onset" and "adult-onset " was avo ided b e­
caus e  o f  the overlap in symp tomology aften seen in patients des cribed as 
having one type or the other . Rather , some o f  the ind ividual signs that 
ar e pr esent in each animal model will be  discussed , with no a t t empt to  
cla s s ify a model as being j uvenile-onset or adult-ons et in nature . 
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collected and then inj ected into a dif f erent species of  animal . Wright 
( 1 96 1 )  has reviewed this model , and comments that of ten the amount o f  
guinea-pig serum required t o  induce the diabetes-like syndrome (hypergly­
c emia , glycosur ia and varying d egrees of  ketonuria) can also induce o ther 
s ever e immuno logic reac tions , which detract from the desirability of  the 
mod el . 
C .  Surgically-induc ed Diabetes . In. this model , animals are subj ected 
t o  a complete pancreatec tomy . Rat s , for example , become hyperg lycemic ,  
glycosuric ,  and ketonuric within 18 hr (Scow , 1 9 57 ) . Rats not maintained 
with insulin die within 48 hr . Unf ortunately , complete pancreatec tomy 
r emoves the exocrine as well as the endocrine func t ions of the pancreas .  
Impaired intestinal absorp tion of  nu trients also  occurs , a charac teris t ic 
no t generally seen in human d iabetes . 
D .  Spontaneous-diabetes. A spontaneously occurring diabetes-like 
syndrome has been r ep or ted to occur in many species , inc lud ing d o gs , cats , 
cattl e ,  sheep , horses , pigs , monkeys , shrews , hippopotomi , foxes , d olphins, 
s ekoke carp , ayu-f ish and s everal rodents (Renold et  al . ,  197 4 ) . Rod ents  
have become the animals of choice as models of  human diabetes becau s e  o f  
their s i z e ,  ease of handling , relatively low co s t  and relatively high 
frequency of  occurr ence of the diabetes-like syndrome . Rod ent models  may 
be divided into two categories , keto tic and non-ketotic. Unt il recently , 
the only rodent model of  ke totic d iabetes was the Chinese hamster 
(Gerr itsen and Dulin , 1967 ) . These animals ar e non-obes e ,  hyperglycemic , 
glycosuric ,  severely keto tic , insulin-respons ive and have increas ed fast­
ing l iver glycogen and circulating free fatty acid levels . The charac t er­
is tics , etiology and genetics of this mod el have been pains takingly s tudied 
(Shirai et al . , 1967 ; Sims and Landau , 1 9 6 7 ;  Malaisse et al . ,  1 9 6 7 ;  
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Carpenter et  a1 . ,  1 9 6 7; Gund ers en e t  al . , 1967;  S irek and S ir ek ,  1 9 6 7 ;  
Schmidt et a1 . , 1 9 7 0; Carpenter et  a1 . , 197 0; Gerritsen and Blanks , 1 9 7 0; 
Chang and Schneid er , 1 9 7 0; Gerritsen and Blanks , 1974; Chang , 1 9 7 4 ;  Chang 
et a1 . , 1 9 7 7 a  and b; Petersson et a1 . , 1 9 7 7 ) . However , their poor t emp er a-
ment and breeding peculiar ities have prevented Chinese hams ter s  from be-
coming a widely used model for s tudying human d iabe tes mellitus ( S chwentker , 
1 9 57 ) . In 1 9 7 7 , Nakhooda e t  a1 . repor t ed a spontaneous diabetic  syndrome 
in ou tbred Wis tar rats of both sexes . Like the hams t ers , the s e  animal s  
ar e non-obes e ,  insulin-respons ive , hyperglycemic ,  and show varying degrees 
o f  ketonemia . Further charac t erization and breed ing of thes e  animals is 
currently underway . 
Of the several non-keto t ic spontaneously-diabetic animal models of 
d iabetes  mellitus , the two mos t  popular are the yellow KK mic e , and the 
d b /db mic e .  The KK mice are obese, hyp erglycemic , etc . , bu t not insu1in-
respons ive .  They have been shown t o  b e  hyperinsu1inemic , and presumed t o  
have a defec t  in insulin utiliza t ion . These animals  are no t generally 
available in the United States (Nakamura and Yamada ,  1967; Yamada and 
Nakamura ,  196 9; Iwatsuka et a 1 . , 1 9 7 0; Iwatsuka and Shino , 1 9 7 0; Wehner e t  
a1 . , 1 9 7 2) .  In add ition , the diabetes- like condition und ergo es r emi s s ion 
by four months of age (Iwatsuka � a1., 1974a and b). The recessive gene 
"db" ( curr ently linked to the mis ty color "m" gene -- "dbm" ) was f ir s t  r e­
ported in the C57BL/Ks mouse strain in 1 9 6 6  (Hummel et al . , 196 6) . Like 
the KK mice , the homo zygous (dbm/dbm) mice are obes e ,  hyperglycemic , non-
ketot ic and no t insulin-respons ive . Their genetics , characteris tics , 
metabolism ,  etc . have b een extens ively s tudied and reviewed (Hummel e t  al . , 
1 9 6 6; Coleman and Hummel ,  1967;  Like et  a1 . ,  197 2; Hummel et  a1 . , 1 9 7 2; 
S taat s , 197 5; Chan et a1 . , 1 9 7 5; Chan and Exton , 1 9 7 7 ;  Coleman , 1 9 7 9 ) . 
--
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Becaus e  the dbm/dbm mice (bo th s exes) are s terile , hetero zygo tic  pairs 
mus t  be mated , yielding , on the average , one d iabe tic (determined a t  f our 
weeks of  age) of each s ex p er eight o f f spring . Their availab ility i s  
l imited and their cost  is currently $ll /mouse. 
E. Chemically-induc ed Diabetes . The use of  chemicals to alter in­
sulin production, secretion and / or utilization is for s everal reasons the 
mos t  p opular means f or caus ing diabetic syndromes in animals. Vir tually 
any species of  animal can b e  rendered d iabe tic . The cost  of a diab eto­
g enic agent is far les s  than that f or spontaneous ly-diabetic animals.  
Dif f er ent degrees of s ever i ty can be  produc ed by adj usting the d o s e  o f  
t h e  diabetogenic agent. Many d if f er ent chemicals have been discovered to  
be diabetogenic agents ,  inc luding 5 , 5-diphenyl-2-thiohydanto in (Mackerer 
� a l . , 197 7 ) , dehydroascorbic acid (Pat t erson , 194 9) , several chelat ing 
agents including l-hydr oxyacr id ine , potas s ium xanthate and Styrlquinoline 
90 (Rerup , 1 9 7 0) and even Vacor , a currently used r odenticide (Pont e t  
a l . , 1 9 7 9) . The two mo s t  popular diabetogenic agents are alloxan and 
s tr ep to zo tocin .  Alloxan-induced diabe tes was f ir s t  reported to occur in 
1 943 in r ats (Dunn and McLetchie , 1943) , rabbi t s  (Bailey and Bailey , 1 943) 
and dogs (Go ldner and Gomor i ,  1943) . The only animal reported to b e  r e­
sistant to alloxan diabetogenesis was the guinea pig (West and Highet, 
1 94 8) . In addition to  hyperglyc emia and glucosur ia , alloxan-d iab e t ic 
animals show a weight los s , hyperlipemia , ketonuria , and acidosis ( Rerup , 
1 9 7 0) .  The metabolic consequ ences o f  alloxan-induced d iabetes have been 
extens ively s tudied (Dixon et a l . , 1 9 6 1 ; Maur er e t  al . ,  1 9 7 2 ;  Ithakis s io s  
e t  al. , 1 9 7 4; Reaven et al. , 197 7; Peavy et al . , 19 7 8 ; Rinaudo et al., 
197 8; Awadallah et al . , 1 9 7 9) .  Unfortunat ely , alloxan adminis tra tion can 
produce toxic ef f ec ts not d ir ec t ly related to its  d iabetogenic ac tion. 
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The kidney is mo st  seriously aff ec ted . Vacuo lation or hydropic changes , 
necrosis and desquamation of  the tubular cells can occur , wher eas the 
glomeruli appear normal . Toxic liver changes have not been repor t ed c on­
s is t ently , but include fatty inf iltration and central lobular necros i s . 
Some investigators have r epor t ed necr os is in the adrenal medulla and an­
t er ior pituitary gland . All these effects have been reviewed by Rerup 
( 1 970 ) . It was the lack of spec if icity of alloxan that has led to  the 
current popular ity of  s tr ep to zotocin (STZ) as a d iabetogenic agent . STZ 
was f or tuitously r ecognized as a diabetogenic agent in 1963  ( Rakieten 
e t  a l . ) dur ing prec linical tr ials as an ant icancer chemotherapeutic agent . 
It is highly soluble but labile in water , and mus t be prepared at  a pH = 
4 . 0 and used within 60  sec of  dissolution . It  was found to b e  d iabe togenic 
in all species tes ted (Rerup , 197 0 ) . Several inves tigators have c ompared 
and contrasted STZ- and alloxan-induced diabetes (Mansf ord and Opie , 1 9 6 8 ; 
Rerup and Tarding , 19 6 9 ; Veleminsky et al . , 197 0) . Unlike alloxan-induced 
d iabe t ic animals , animals inj ec ted with STZ are not generally ke t o t ic and 
never r eturn to their age-normal weight unless  insulin is admini s t er ed . 
The mechanisms by which alloxan and STZ cause d iabetes are also thought to  
be d if f erent s ince the manifes tat ions and cons equences of their respec t ive 
diabetic states differ. Almost 1000 papers have been published on the 
characteristics  of  STZ- induc ed diabetes and its ef f ec t s  on the body . 
The mechanism ( s) by which STZ causes diabetes is (ar e) not c lear , 
a lthough some inf ormat ion is availab le . Severe necr o s is of  the S-cells o f  
the p ancr eas has been obs erved a s  has islet atrophy (Wilander , 197 5 ) .  
Nuclear enlar gement and nucleolar loss in the S-cells have also been re­
ported (Lazarus and Shapir o ,  19 7 2 ) . Nicotinamide can prevent STZ-induced 
d iabe tes by preventing the STZ- induc ed decrease in pyr idine nucleo t id e  
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content of  the pancreatic is lets (Schein et al . , 1967 ) which accounts for 
the pr evailing hypothesis that an int erac tion be tween STZ and DNA caus e s  
diabe tes (Hinz and Pf eif f er , 1 9 7 4 ) . However , the ant itumor ef f ec t  o f  STZ 
is  no t modified by nicot inamide . This theory of  STZ-DNA interac t ion is 
fur ther supported by the observation that STZ-induc ed diabetes can b e  pr e­
vented by pretreatment with pertu s s is vaccine (Katada and Ui , 1 9 7 7 ) , where 
only a transient hyperglycemic s tate is s een . Also , STZ is  a nitr o s amine 
d erivative , and so may act as an alkylating agent (Rakieten � al . , 19 6 3 ) . 
Becaus e  of  its spec if ic ity o f  ef f ec t  in caus ing diabetes , and the lar ge 
data base available , STZ was chos en as the agent to be used in producing 
diabe tes . 
Several pharmacologic agents have been shown to af fec t  insulin s ecre­
t ion and / or blood glucose levels .  Some agent s can produce oppo sit e e f f e c t s  
o n  blood glucose levels due to d if f erent conditions of adminis tration . 
Diphenylhydanto in administration inhibits insulin secretion in the iso­
lated p erfused rat pancreas (Levin et al . ,  1 9 7 0 ) . Diaz oxide , an ant ihyper­
t ens ive agent , causes hyp erglycemia in dogs (Speight and Avery , 1 9 7 1 ) , and 
chlordiazepoxide can aggravate d iabetic hyp erglycemia in humans ( Zumof f  
and Hellman, 1977) .  Ethano l can caus e hypoglycemia , a s  can propranalol , 
s tero id s , salicylates , several diuretics and pheno thiazines (Hans ten, 1 9 7 1 ) . 
Hyper glycemia can be  induced by salicylates , caf f eine, pheno thiaz ine s , 
steroids , ep inephrine , furos emide , heparin , imipramine , morphine and o ther 
drugs (Hans ten, 1971) . 
It  has been known for some time , that intraventricularly adminis tered 
insulin can cause a promp t ,  prof ound hypoglycemic resp onse in laboratory 
animals (Chower s et al . , 1 9 6 6 ; Szabo and Szabo , 197 2) .  Controver sy exis t s  
however , a s  t o  whether this ef f ec t  i s  due t o  leakage into the sys t emic 
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circulation and / or a centrally mediated s timulation of pancreatic insulin 
release (Woods and Por t e ,  1 9 7 5) or t o  a centrally mediated increas e in 
glucose  up take by the l iver without hyper insulinemia (Szabo and Szab o , 
1 9 7 5a ,  b ,  c) . Circums tantial evidence sugges t ed that the presumed insulin 
"receptors" wer e localized in the ventromedial hypothalamus (Storlien e t  
a l . , 1 9 7 5) . Havrankova et  al . ( 1 9 7 8a) , determined wher e the specif ic 
b" d
'
" f 12 51 "  I "  t b " h d d d d 1n 1ng 0 -1nsu 1n to  ra ra1n omogenates occurre , an emons trate 
the wide though uneven dis tr ibut ion of binding sites throughout the rat  
CNS . No ar ea of the brain was without thes e  bind ing sites . Later , the s e  
inves t igators reported levels of  insulin in the brain from 10 to  1 0 0  t imes 
the s erum level (Havrankova et al . , 197 9) . Insul in binding sit es wer e  
demonstrated o n  synap tosomes , lead ing these  inves tigators t o  pos tulate  
a r o le for  insulin as a neuro transmitter (Havrankova et al . , 19 7 9 ; P ac o ld 
e t  al . ,  1 9 7 9) . This hypo thesis has yet to be  proven . In genet ically 
obese mice ,  wher e s erum insulin levels ar e high , and insulin recep tor 
l evels in liver, fat and o ther tissues are low (Stauffacher et  al . ,  1 9 6 7 ;  
Kahn et  al . , 1 9 7 3; SolI et  al . ,  197 5) , normal concentrations o f  insulin 
and insulin binding s ites are present in the brain (Havrankova et al . ,  
1 9 7 8b) . The same is true for STZ-induc ed diabetic rats (Havrankova e t  al . , 
1 978b; W.G. Blackard , personal communication) . The ob s ervat ion that the 
levels o f  insulin and numbers of insulin binding sites are normal in the 
brains of STZ-induced d iabetic rats does no t necessarily mean that the 
sys tem ( s) in which these two components have func tions operate proper ly . 
For example , it has been reported that the res ting serotoner gic levels and 
turnover in STZ-induced d iabetic rats ar e normal (Mackenz ie and Trulson , 
1 9 7 8 c , e) but the s erotonergic system does no t respond normally to pharma-
cologic manipulation (Fernando and Cur zon , 1 9 7 8) . Evidence which support s  
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the po s i tion that the c entral glucor egulatory system in diabe tic animals 
is abnormal was recently published by Coimbra et al . ( 1 9 7 9 ) . They r eport­
ed the f ollowing : In non-diabetic rats , if gluc ose or insulin is inj ec ted 
intraventricularly , plasma free fatty ac id l evels ar e markedly reduc ed . 
In alloxan-induced diabetic rat s , plasma free fatty ac id levels were no t 
a f f ec ted by intraventr icularly adminis t ered glucos e , but wer e decreased by 
intraventricularly adminis t er ed insulin . Thus , the CNS glucor egulatory 
system appears to be  func t ionally altered in d iabetic rats . Exp erimentally­
induc ed diabetes has already been shown to af fect  carbohydrate me tabolism 
in the brain (Prasannan and Subramanvan , 1968 ; Flock et al . , 1 9 6 9 ; Ruderman 
e t  al . , 197 4) . These alterations are revers ed by insulin adminis tration 
(Rinaudo et al . , 197 8 ) . The diabetes-induc ed changes in brain carbohydrate 
metabolism could interact with drugs that have effects  on brain carbohydrate 
metabolism, e.g . morphine (King et al . ,  197 7 , 1 97 8 ) . 
There are conflicting r eport s  in the literature concerning the e f f ec ts 
of  diabetes (or other conditions that alter blood glucose levels ) in alter­
ing the sens itivity of  animals to drugs . As early as 1 9 5 1 , Lamson e t  ale 
d emons tra ted that the inj ec tion of  gluco s e  i . v .  in a dog awakening from 
p entobarbital- induced anes the s ia caused a promp t return to narco s is . This 
could b e  repeated several times in the same animal , with the duration o f  
anes thes ia decreas ing af ter each glucose  inj ec tion until thes e  inj e c tions 
no longer had any ef f ec t .  This effect  was sub sequently shown t o  occur in 
s ever al o ther spec ies (hams ter , rabbit , guinea p ig) but not the rat or 
mouse . This  ef fect of  glucos e  was s een only in animal s anesthetized with 
each of the five diff er ent barb iturates tried , but no t with any of s even 
volatile anes thetics tes ted . Borzelleca and Manthei ( 1957)  have shown 
that dehydration and changes in acid-base balance can alter the duration 
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o f  action of  phenobarbital . Bo th of  these ar e characteristic s  o f  human 
diab et es mellitus (Tepperman� 1 9 7 3 ) . Strother et al . ( 1 9 7 1 ) and Stro ther 
( 1 9 7 9 )  repor ted that the intake of  large amounts  of glucose  in the dr ink-
ing wat er f or 48 hr increased the duration of anes thes ia induced by s everal 
b arbi turates , and decreased the in vitro metabolism of  barbiturates and p-
n itroanisole in mic e . Ackerman and Leibman ( 19 7 5) and Ackerman ( 19 7 6 )  
r ep ort ed that STZ-induced d iabetes  in rats reduc ed the in vitro activity 
o f  hexobarbital hydroxylation� and had no ef fect  on aniline hydroxylation . 
In addition, they reported that continuou s  infus ion of gluco s e  had no 
ef f ec t  on the hydroxylation of  hexobarbital . In contras t  Reinke et al. 
( 1 9 7 7  and 197 8 )  r ep or ted marked increas e s  in aniline hydroxylas e ac t ivity 
in STZ-induced d iabetic rats . 
Hanasono et al . ( 1 9 7 5 a  and b )  have repor t ed that carbon t e trachlor ide-
induc ed hepatotoxicity (determined morphologically and by liver func t ion 
tes ting) was increas ed in STZ- and alloxan-induced diabetic rats compared 
with nondiabetic rats . Insulin-treated diabetic rats were aff ec t ed by ex-
p osur e  to carbon tetrachlor id e  only to the same extent as nondiabe t ic rats . 
Some investigations (Arms trong and Doll , 1 9 7 5; Walsh et al . , 1 9 7 7) 
have been concerned with the combined e f f ec t s  of diabetes and c igar e t t e  
smoking upon the incidence of bladder cancer and with alterations by 
c ig arette  smoke on blood sugar levels , and s erum insulin and non-es terif i-
ed fatty acid levels , respec tively , in humans. No apparent interactions 
were observed . No other report s  on the toxic ity of nicotine in d iabeti c  
animals or humans ar e available . 
Diabetes mellitus has many adverse  e f f ec t s  on the autonomic nervous 
system and reactions to s tress  (Faerman et al . ,  1 9 7 4; Stewar t e t  al . ,  
1 9 7 6; Fraser et al . , 1977;  Bennet t  et al . , 1 9 7 7 ;  Head and Berkowi t z , 1 9 7 7 ;  
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Eden et  al . , 197 7 ;  Fukuma et al . , 1 9 7 8 ) . De Nicola � al . ( 1 9 7 7 )  have re­
por ted that in STZ-induced d iabetic rats , res ting ACTH and cor t ico s t erone 
levels were signif icantly higher than in nond iabetic rats , mimicking a 
c ondi tion of chronic stress . These animals also s ecreted signif icantly 
more corticos terone than nond iabetic c ontrols when s tressed with an inj ec­
t ion o f  cold water . They conc luded that the threshold for s t er o id f eedback 
was ' les s sensitive to variations in plasma cor t icos terone levels . Zapf e t  
a l .  ( 1 9 7 5) have shown that STZ- induc ed diabetic rats were hyp o s ens i t ive t o  
the lipolytic ef f ec ts of ACTH and glucagon , but hyper sens itive to  the 
l ipolytic ef f ec t s  of ep inephrine . Insulin adminis tration rever s ed the 
hyper sens itivity to ep inephrine . High plasma levels of  corticos terone 
accompanied by abnormally high ACTH secretion has been seen in newly d iag­
no s ed cases of human diabetes mellitus (W . G .  Blackard , personal communica­
t ion) which could result from a " s tarvation"- induced s tress reac tion . 
These  high levels of ACTH in human and exper imental diabetes are impor tant 
when one cons ider s that ACTH has been shown to inhibit  the ant inoc icep t ive 
p o tency of morphine ( Takemori ,  1 9 7 6) and inhib it the s tereospecific  b ind­
ing of dihydromorphine ( Terenius , 1 9 7 5) . 
Ther e have been other r epor t s  in the literatur e which sugges t a d irect  
int eraction between exper imental diabetes and an animal ' s sens itivity to  
c entrally-act ing drugs . Mar shall et  al . ( 19 7 6) have shown that alloxan­
induc ed d iabe tic rats have a d ecreased sensitivity to the anor exic and loco­
mo tor-stimulating ac tions of  d-amphetamine . Thi s  effect could be  p artially 
r ever s ed by f eeding the diabetic rats a diet containing a high fat /pro tein 
ratio , which also par t ially ameliorates the d iabetic-hyperglycemia (Mar shall , 
1 9 7 8b) . Mackenzie and Trulson ( 1 9 7 8d) have repor ted that STZ-induc ed d ia­
betic rats had a reduced sens itivity to L- tryptophan and p-chloroampheta-
mine . The occurrance o f  a behavioral syndrome cons i s t ing of  r e s t ing 
tremor , rigid ity or hypertonicity , hind limb abduc tion , Straub tail , 
lateral head weaving and reciprocal f orepaw treading was used in thes e 
s tudies to assess the rats ' s ens itivity to the drugs (Jacob s , 19 7 6 ) . 
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Morphine has been shown to cau s e  hyp er glycemia in rats (Borison e t  
a l . , 1 9 62 )  b y  interacting at  a s ite i n  the subf ornical region o f  the brain 
( Bor ison et al . , 1 9 64 ; Moor e et  al . ,  1 9 65 ) . Apomorphine and etorphine 
p roduce marked hyp erglycemia , but meper idine does so only weakly (Dey and 
Feldber g ,  197 5 ) . Endogenous opiate-like p ep t ides and morphine have been 
shown to aff ec t  several neuroendocrine func tions at the hypo thalamic level 
in rats (Meites et al . , 197 9 ) . Thyro tr opin releasing hormone caus ed "wet 
dog shakes" in rats , similar to  those  obs erved dur ing morphine withdrawal 
(Mar t in et al . , 197 7 ) . Morphine adminis tration blocked this ef f ec t . 
Reed and Ghods e  ( 1 9 7 3 )  have rep or t ed that hero in addicts showed a d elayed 
and attenua ted incr eas e  in blood sugar levels following an oral glu c o s e  
to lerance t es t .  Res t ing insulin levels wer e  higher in add icts than non­
add icts , and the increase  in plasma insulin levels in respons e to the 
g lucose challenge was delayed and attenuat ed . Bramb illa et  al . ( 1 9 7 6 )  
have conf irmed these f indings ,  excep t that they repor ted an incr eas e in 
p lasma insulin levels in addicts following a glucose  challenge . Ghods e  
( 1 9 7 7 )  subsequently conf irmed all the r esul t s  o f  Brambilla e t  al . ( 1 9 7 6 ) . 
Les lie et al . ( 1 9 7 9 )  have pos tulated that non-insulin-dependent diabetes  
melli tus in humans might be due to  an  innate hypers ens itivity to  endogenous 
o p iate- like p ep tides , although the evidenc e to support this hypo the s i s  is 
c ir cums tantial . 
These  many observations ind icate that pharmacologic intervention and 
endocr ine func t ion in general , and ef f ec t s  secondary to diabe tes mellitus 
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in par ticular , can play an impor tant  role in drug responses . 
Ther e are ,  in addition ,  many factors that can af f ect  the p o t ency o f  
narco tics . Several of  these factor s  may be impor tant in d iabetes . Glu­
cagon can inhibit morphine-induced motor wave act ivity of the dis tal colon 
and rectum ( Chowdhury and Lorber , 1 9 7 7 ) . Harris e t  al e ( 1 9? 5 )  have r epor t ­
e d  that intraventricular inj ections of calcium , magnesium o r  manganes e  
ions can antagonize  the antinocicep tive eff ec t s  o f  morphine . Luj an e t  al e 
( 1 9 7 8 )  conf irmed the r esult s  with calc ium and ext ended the work to  includ e 
s od ium. Electrolyte imbalance is not uncommon in diabe tes ( Tepperman , 
1 9 7 3 ) , sugges t ing that the ant inociceptive potency of  narcotics could b e  
alter ed in diabetic individuals .  
Webs ter et al e ( 1 9 7 6 )  have shown that old mice are signif icantly less  
s ens itive to  morphine than are young adults . Ac tinomycin D ,  s t er o id s , 
promethazine , atropine , aspar t ic acid , prostaglandin E ,  and bar b i turates 
have been shown to antagonize narcotic- induc ed analges ia , whereas sulpho­
namides , daunomycin and ouabain have been rep or t ed to potentiate analges ia 
( Takemori , 197 6 ) . Many neuro transmitter s , and drugs which af fect  neuro­
t ransmiss ion have been repor ted to af f ec t  narco tic potency . Clas ses  o f  
drugs r epor ted t o  decrease narcotic potency include biogenic amine deple­
t or s , dopaminergic stimulators , a-adrenergic blockers , anticholener gics , 
monamine oxidase inhib itors , neurotransmitter precur s ors , anxiolytic  drugs , 
cyclic nucleo tides , ant ip sycho t ics  and hallucino gens ; while cathechola­
mines , amphetamines , cocaine , L-dopa ,  dopaminer gic blockers , a-adr energic 
b locker s , ant idepressant s ,  antipsycho tics , monoamine oxidase inhib itors , 
s erotonin and parasympathomimetics have been repor t ed to potentiate nar­
c o t ic action (Dewey et al . , 1 9 7 0 ;  Calcutt  et al . , 19 7 1 ;  Hans ten ,  1 9 7 1 ; 
Maj or and Pl eavry , 1 97 1 ;  Sparkes and Spencer , 19 7 1 ;  Scheel-Kruger , 1 9 7 3 ; 
1 5  
Tulunay et  al . , 1 97 3 ;  Takemori , 1 97 6 ;  Maickel et al . ,  197 6 ;  Carenzi ,  1 9 7 8 ; 
Sprague and Takemori ,  197 8 ) . 
In a paper providing limited procedural detail , Davis e t  al . ( 1 9 5 6 )  
r epor ted that insulin-induc ed hypoglycemia potentiated the antinoc icep t ive 
act ion of  morphine in the rat tail-f lick tes t .  Us ing two d if f er ent d o s e s  
o f  glucose and two dif f er ent routes of adminis tration , they found n o  d o s e­
r elated ef f ec t s  o f  glucose adminis tration on the antinocicep tive p o t ency 
of morphine wer e  observed . They did not attemp t to correlate b lood g lu­
c o s e  levels with changes in the potency of morphine . S ince hyper insulinemia 
will persist af ter , and hypoglycemia will o f t en f ollow gluco s e- induced 
hyper glycemia ( Tepperman , 1 9 7 3 ; Mats chinsky et  al . , 1 9 7 5 ) , inf ormation 
c oncerning blood glucose levels at all time points where antinocicep t ion 
was assessed is essential f or a proper interpretation of the data . It  i s  
f or this reason that morphine- induc ed antinocicep tion in STZ-induced dia­
b e t ic animals was inves tigated together with an as sessment o f  key bio­
chemical ind ices . 
The tail f lick tes t (D ' Amour and Smith , 1 9 4 1 ) , as mod ified by Dewey 
et al . (1970) , was used to comp ar e  the antinocicep tive potency of  morphine 
in diabetic and contr ol mic e .  This proc edure i s  a very specific tes t for 
analges ics of  the morphine- type .  Although s everal o ther methods which in­
volve r esponses o ther than the tail-flick ref lex ar e available for as s e s s ­
ing narco tic- induced antino cicep tion (Randall and Selitto , 1 95 7 ; Pear l  and 
Harris , 1 96 6 ;  Fennes sy and Lee , 1 9 7 5 ) , the tail-flick tes t has been the 
mo s t  widely used . Nocicep tive s t imuli such as ho t water (Ben-Bas sat et  
al . , 1 9 5 9 ) , radiant heat of f ixed intensity and var iable duration (D ' Amour 
and Smith , 1941)  or rad iant heat of f ixed duration and variable int ens ity 
( Hardy et al . , 1940)  have been used in this tes t .  Rad iant heat o f  f ixed 
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intensity was used in this disser tation . Generally , mechanical t echniques ,  
electrical stimulation and behavioral tes ts either r equire sophis ticated 
equipment or long preparatory t ime ,  or have limited reproduc ib ility 
( Fennes sy and Lee , 197 5 ) . 
The purpose of thes e inves tigations was to  determine which port ion o f  
the diabetic syndrome primar ily was r espons ible for the altered s ens itivity 
to  morphine obs erved in p ilot exper iments .  Additional experiment s  wer e  
des igned in att empt t o  elucidate the mechanism of  how this por tion o f  the 
pathophysiological syndrome in turn altered the potency in diabetic mice . 
It is hop ed that thes e results  might provide some ins ight into the pathol­
o gy o f  diabet es mellitus and /or the mechanism of  act ion of  morphine . 
METHODS 
I .  General Me thods and Pre treatments 
Female animals wer e used , s ince in humans , d iabetes mellitu s  is  r e­
p or ted to be  more s evere in f emales than males (Amer . Diab . As s . , 1 97 6 ;  
Bale and Entmacher , 197 7 ) . Using female animals might increase the prob­
ability of d etecting diabe tes-induc ed changes in s ens itivity to the drugs 
u s ed in these s tudies . The species and s trains o f  animals us ed were : 
Outbred ICR Swiss  mice (weighing 15- 3 0  g ) ; outbred Sprague-Dawley rats  
( 200- 250 g) ; and C57BL/KsJ (dbm/++ or dbm/dbm) mice ( 20-4 5  g) . All drugs  
were dissolved in distilled water exc ep t S TZ which was dissolved in 0 . 01 
M s od ium ci trate , adj us ted to a pH of  4 . 0 wi th HCl .  In all s tatis t ical 
analyses , p < 0 . 05 was considered to be s ignificant . 
The following pretr eatments were adminis tered to animals to induc e  
d iab e tes o r  to mod ify their blood gluco s e  levels ( BGL ' s ) . Data from pre­
liminary s tud ies were used to determine the optimum dosages and pretrea t­
ment times . BGL ' s at  the appropriate times ar e shown in s ec tion IV A .  o f  
the Results . All animals were allowed access  t o  food and water a d  l ib i tum 
unl es s  o therwis e indica ted . 
A. Swiss Mice 
1 .  Control . No  pretreatment . 
2 .  S TZ-diabe tic . S TZ was supplied by the Upj ohn Co . and admin­
i s t er ed ( 200 mg/kg i . v . ) no t les s than 6 days prior to the experimental 
day . The ac tual number of days is repor ted in the Results sec tion for 
each exp eriment . Observations were recorded on the effects  of STZ-induced 
diab etes on body weight and survival for 1 2 6  days following S TZ adminis-
tration . 
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3 .  Insulin-managed STZ-d iabetic . Lilly regular porc ine insulin 
( 3  U / kg s . c . )  was adminis t ered to STZ-diabetics (as in 2 .  above ) 2 0  min b e­
f ore drug treatment . BGL ' s wer e determined in each animal during each ex­
p er iment to ver ify the return of BGL ' s to normal . This dose was necessary 
to achieve normal blood glucose levels .  
4 .  Sugar s .  Either dextr o s e , fruc tose or 3-0-methyl gluco s e  
( Sigma) was adminis tered (0 . 028 mol /kg i . p . ) 2 5  min prior to drug treat­
ment . Adminis tration of  d extr o s e  produced hyperglycemia which p er s i s ted ' 
f or about 90 min . 
5 .  Fas ted . Animals were allowed access t o  water only for  18 
hr prior to drug treatment . 
6 .  Fas ted plus (+) insulin . Lilly regular porc ine insul in 
( 1  U/kg s . c . ) was adminis t er ed to fas ted animals (as in 5 .  above) 20  min 
before drug treatment . This dose was suf f ic ient to cause hypoglycemia for 
> 120 min . 
B .  Rats 
1 .  Control . No pretreatment . 
2 .  STZ-diabetic . STZ ( 6 0  mg /kg i . v . ) adminis tered 6 days prior 
to the experimental day . 
C .  C57Bl /KsJ Mice 
No pretreatments were adminis tered . Animals were 6-7 weeks o ld . 
I I . Narcot ic- Induced Antinocicep t ion and Related S tudies 
A.  Tail-Flick Procedur e  
A reliable method f or as s e s s ing the ant inocicep t ive p o t ency o f  
drugs in animals i s  the tail-f l ick tes t .  
1 .  Experimental procedur e .  The procedur e us ed was that o f  
D '  Amour and Smith ( 1 9 4 1 } , as modif ied by Dewey e t  al . ( 1 9 7 0 ) . The tail-
f lick apparatus cons is ted of  a rad iant heat s ourc e ,  pho tocell , timer and 
power supp ly . The heat source was a 100 wat t  proj ection lamp mounted in 
a ref lec tor and s i tua ted above the pho tocell . The intensi ty of  the lamp 
was controlled by a rheo s ta t  on the power supply . The animal ' s  tail was 
p laced in a slit  over the pho tocell , preventing light from reaching the 
pho t� cell . A common switch ac tivated the lamp and the timer . When the 
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animal f licked its  tail , light f ell on the pho tocell , au tomatically s top-
p ing the timer . The lamp intensi ty was adj us ted to give a control f lick 
latency o f  2-4 s ec . Animals whos e  contr o l  latency was out s id e  this  range 
were rej ected . Maximum antinocicep tion f ollowing adminis tration o f  an 
analge s ic ( t e s t  latency ) was def ined as 10 sec (mic e)  or 20 s ec (rats ) . 
Each animal was tes ted before a pretreatment was administered , immediately 
b ef or e  narco tic adminis tration , and 20 min af ter narcotic adminis tration . 
The antinocicep tive ef f ec t  was calculated as the p er c entage 
of  the maximum pos s ible ef f ec t  us ing the formula : 
Tes t latency-control latency ( s ec ) 
1 0  (mice) or 20  (rats ) sec  x 100  = % Maximum pos s ib l e  ef f ec t  (% MPE) 
At leas t thr ee doses o f  each narco t ic per pretreatment wer e tes t ed . For 
s tatis tical calculations , doses were conver t ed to log doses . 
2 .  S tatis tical evaluation . An analys is of covarianc e was used 
to tes t for a s tatis tically s ignificant shif t of  the dose-respons e curve 
(DRC ) f or each pretreatment group vs control ( Barr et al . , 197 6 ) . The % 
MPE f or each animal o f  all pretreatment group s was ent er ed into a SAS 
c ompu t er . The computer generated a s ingle linear r egres s ion which bes t 
f i t  all data points ( log  narco tic dos e ,  % MPE) . If  the raw data f r om any 
pretreatment group did no t f i t  the regres s ion line generated , the pro gram 
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would b e  rej ec ted . This never occurred . The y- intercep t  (b ) for the r e-
gress ion line and each pretreatment ' s  DRC was determined by the computer , 
as wer e the slope of the curves (m) , the mean s quare err or ( 82 ) , the number 
of degrees of freed om (Nt ) and the c orr ec t ed sum of s quares ( � 8xx) . The 
log of the potency ratio (log  M) of  a nar cotic in a pretreatment group vs 
c ontrol is described by : log M (Xc - Xp) - (Ye b Yp) where Xc and Xp are 
the mean doses administered the contr o l  and pretr eatment group s , respec-
tively , and Yc and Yp are the mean % MPE for the c ontrol and pre treatment 
groups , respectively . The 9 5 %  conf idence limits of  the log of the potency 
ratio is described by : M + ( lo g  R) ( t )  where log R = s tandard d eviat ion 
o f  log M and t = the cr itical value of  t f or Nt degrees of freedom . Log 
R is 
by v 
def ined as the s quare root of  the variance (v) of log M,  d e termined 
_
_
 
8 2 � + �) + ( log M - Xc + Xp) 2 where � nc and np ar e the number m nc np � 8xx ' 
o f  animals tested in the control and pretreatment groups resp ec t ively . 
�Vhen log M and log R have been calculat ed , the ant ilogs of each (M) and 
( R) are calculated . The interval M ± (R) ( t )  mus t  no t inc lude 1 . 00 for 
ther e to be a s ignif icant shif t in the log dose-response curve o f  a pre-
treatment group vs control . 
3 .  Narco t ics  tes ted . The analgesics tes ted in the tail-flick 
tes t were morphine sulf ate , phenazocine hydrobromide , levorphano l tar t-
rate,  methadone hydrochlor id e ,  meperidine hydrochlor ide , and propoxyphene 
hydrochloride . 
B .  Phenylquinone- Induced Writhing Procedur e 
This test  also quantitates narcotic potency in animals , and was 
used to conf irm some of the resul ts seen with the tail-flick tes t .  The 
procedure used was a modif ication of that of Pearl and Harris ( 1 9 6 6 ) . 
Fo llowing the appropriate pretr eatment , mice were inj ected s . c .  with gr aded 
d o s es o f  morphine ( tes t) . Ten minutes later the mic e were inj ec ted i . p .  
with 0 . 1  ml / 10 g of  0 . 03 %  p-phenylquinone ( Sigma) mad e up as a 10%  
e thanolic solution . Beginning 10  minutes later , the number o f  wr ithes 
( s tr etching , twis ting of torso or c ontrac tion of abdomen) f or each mou s e  
was counted f o r  1 min , and then S min later f o r  1 min again . Thus , the 
number of writhes in each mouse was counted for 2 min . For each pre-
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tr eatment tes ted , one group of mic e  received the appropriate pretreatment 
and phenylquinone , but no morphine ( c ontrol) . The % pro tec tion agains t 
( tes t II writhes ) wr i thing was calculated as : % Protec tion 
=
 
1 - ( contro l  II wr ithes ) x 100 . 
The % pro tection for each group was plo tted on log-probit pap er , and the 
EDS O ' s  d etermined by interpo la tion . Then , the 9 S % conf id ence limi ts o f  
the EDSO ' s , s lope func tions and potency ratios wer e calculated by the log-
probit method o f  Li tchf ield and Wilcoxon (1949 ) . 
c .  Duration o f  Ac tion o f  Morphine 
If the absorp tion , metabolism or excretion of morphine wer e 
alter ed by the induction of  STZ-diabetes , this might be  reflec t ed as a 
change in the duration of antinocic ep tive action in the tail f lick tes t 
unless two or more of these parameters were altered in dif f er ent d ir ec tions 
yield ing no net dif f erence . S TZ- induced diabetic and control  mic e  were 
inj ec ted s . c . with 4 mg/kg morphine and then t es ted on the tail-fl ick 
apparatus S ,  10 , 20 , 40 , 80 or 120 min later . At each time point the % 
MPE was calculated as des cribed on page 18 . Due to the p o s s ibility of  
cumula t ive heat- induc ed nerve damage to the tails of  the mic e ,  diff erent 
mice were tes ted at  each time point . 
D .  Naloxone Antagonism of Morphine- Induc ed Antino cicep tion 
A s tudy to determine the pA2 value f or naloxone antagonism o f  
morphine- induced antinocicep t ion i n  the tail-flick tes t ( c ontrol v s  
2 2  
S TZ- induc ed diabetic mice)  was conduc ted in the manner des cribed by 
Takemor i et a l e  ( 1 9 6 9 )  with mod if ication . Af ter the appropriate pretreat-
ment mice wer e adminis t ered naloxone hydrochlorid e  at either 0 ,  0 . 03 ,  0 . 1  
or 0 . 3 mg/kg s . c .  Ten min later , 6 . 0  mg/kg morphine sulfate was adminis-
t er ed by the subcut aneous route . Twenty minutes f ollowing morphine , the 
animals wer e tes t ed f or tail-f lick latency . Statis tical evaluation of  
the data was conducted by the analysis of  covariance ( Barr et  al . , 1 9 7 6 )  
as  des cribed in the sec tion on tail-f lick methods (page 1 9 )  and the method 
of Li tchf ield and Wilcoxon (1949 ) .  The negative logarithm of the d o s e  o f  
naloxone hydrochlor ide that reduc ed the antinociceptive effect of morphine 
alone by 50% = pA2 . If the pA2 values wer e dif f er ent for diabetic and 
c ontr o l  mic e ,  this would sugges t that dif f erent recep tors wer e  being 
b ound by naloxone in the two group s . 
E .  Radiotracer S tudies 
1 .  Preparat ion o f  samples . Tritiated morphine ( 1_3H) wi th a 
s p ecif ic activity of 20-30 Ci/mM was pur chased from Amer sham Corporat ion . 
One hundred uCi of tr itiated morphine was added to a solution o f  4 mg / IO 
ml unlabeled morphine sulf ate . Control , STZ-induc ed diabetic and insulin-
3 inj ec ted STZ- induc ed diabetic mice were adminis tered the H-morphine s o lu-
t ion. The ant inocicep t ive p o t ency o f  morphine was quantitated using the 
tail-flick tes t as descr ibed on page 18 . Immed iately af ter the p o s t-
morphine tail-f lick d etermina tion ,  each mouse was d ec apitated , and trunk 
b lood collected into micro-centr ifuge tubes . The b lood was allowed to 
c lo t  f or 10 min , and then c entrifuged . The supernatant s erum was trans -
f erred to small vials and s tored at - 20 ° C . The brains were dis s ected out , 
cleans ed of adherant blood and dr ied . A mid-sagit tal incis ion was mad e , 
and each brain half was weighed and placed in a paper cone for oxidat ion . 
S erum , tr itium s tandard and 3H-morphine solution samples were p ip e t ted 
onto paper cups ins ide paper cones to facilitate combus tion in the oxi­
d izer . 
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2 .  Tissue oxidation . Br ain sec tions and serum samples wer e  
c ombus ted in a Packard Tr i-Carb mod el #B306 tissue oxidi z er . This  pro­
c edur e allowed the 3H present in the samples to b e  carried by H20 into 
Packard Monophase-40 scintillation cocktail for counting . Brain samp les 
wi th known amounts of  rad ioactivity added and brain samples with no rad io­
activity (b lank) also were combus ted to determine % recovery and % memory 
(retention) in the oxidizer . All s tandard and blank samples were c ounted 
in a Beckman model #LS-3l33T liquid s c intillation counter before any o ther 
samples wer e combus ted to assure proper func tioning of  the oxidi z er (vir­
tually 100% r ecovery and 0% memory) . Samples of the drug solu tion admin­
is ter ed to the mice wer e combus ted and counted to determine the number o f  
cpm/mg o f  morphine . This value was used in the determination of  morphine 
l evels in brain and s erum. 
Samp le s izes for combus tion wer e 25 ul for serum ( in dup li­
cate) , and drug solut ions , s tandard solutions and blank solutions ( in trip­
licate) . The right and lef t halves of each brain wer e oxidized sep arately . 
The amount of time necessary for complete combus tion was 10 sec / liquid 
s amp le and 1 min/brain sample . 
3 .  Liquid scintilla tion counting . The cocktail from the oxi­
d izer was dispensed into plas tic scintillation vials which were capp ed , 
shaken vigorous ly f or 10 sec  and then let s tand overnight to eliminate  
chemiluminescence . Vials were then p laced in the Beckman counter and pro­
grammed f or 10 min counting or no t greater than 2% counting error , which­
ever occurr ed firs t .  The counter also was programmed t o  det ermine the ex-
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t ernal s tandards ratio ( ESR) f or each sample ( a  r ela tive measure of  the 
amount of quench by water in each vial) . ,  The mean number of counts p er 
minute (cpm) from at leas t 10 blank samples was sub tracted from the number 
of  cpm determined for each sample vial , yield ing a net number of  cpm . 
A quench curve for the counter had previous ly been generated 
3 by adding known amounts  of  H and water to Packard Monophas e-40  cocktai l , 
and then plot ting the % counting efficiency (ob tained from the number o f  
cpm reported by the counter )  v s  the ESR determined b y  the counter f o r  each 
s ample . The % counting eff iciency was def ined as : 
II cpm detec ted 
II cpm added x 100 = % counting ef f iciency 
From the ESR determined by . the counter for each unknown sample the counting 
ef f iciency (in these experiments 25-3 2 % )  was determined by reading di-
rec tly from the curve . The number of  disintegrations per minute (dpm) was 
determined by the equation : 
cpm x 100 dpm = -% count ing ef f iciency 
The number of dpm in each mous e ' s  serum sample was averaged yield ing dpm/ 
5 ul s erum . In brain halves , dpm/brain-half wer e added yielding t o tal 
numb er of  dpm/ to tal brain weight . The number of  dpm/ml s erum or / g  brain 
was then d e termined by s imp le p ropor tions . From the known specific activ-
i ty (II dpm/ng morphine) of the drug solution ; the number of ng Eq morphine / 
ml serum or / g  brain wer e  determined . The term "Eq" is used to s ignify 
that all 3H pres ent was assumed to be in the form of 3H-morphine . 
S tudent ' s  t- tes t was used to detec t s tatis tically s igni f icant 
d if f erenc es in serum or brain morphine Eq levels . 
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I I I . Other Pharmacologic S tudies 
A. LDSO Determinations 
Changes in the antinoc iceptive potency of narcotics due to al-
t ered blood glucose levels may no t r eliably predict  changes in lethali ty , 
i f  the mechanisms by which antinocicep tion and le thali ty occur ar e no t the 
s ame . The log-probit method of Litchf ield and Wilcoxon (1949 ) was us ed to 
c ons truc t dose-respons e curves for the acute  lethality of subcutaneous ly 
adminis tered morphine or methadone in STZ-induced diab etic and contr o l  
mice . Nico tine was also tes ted s ince many diabetics smoke . Groups o f  at  
least s ix animals wer e administered each dose of the tes t drug . The p er-
centage of animals dead by 24 hr following drug adminis tration was us ed as 
the endpoint in the s tatist ical calculations . The LD 50 of each drug in 
each p retreatment group was determined from the curves cons truc ted , and 
the 9 5% conf idence limi ts of  the LDSO ' slope func tions and po tency ratios 
were calculated according to the log-probit  method (Litchf ield and Wilcoxon , 
1 9 4 9 ) . 
B .  Duration of Hexobarbital-Induced Anes thes ia 
Other inves tigators have published conf lic ting rep or t s  on the 
e f f ec ts of altering BGL ' s on the subs equent metabolism of barbi turates in 
v i t ro . We d e c id ed to inves tiga t e  the e f f e c t of al tering BGL ' s  on the 
ac tion of barbiturates in vivo . Control , STZ-induced d iabetic and dextr o s e-
pretr eated mic e were inj ec ted i . v .  with 100 mg /kg hexobarbital sodium .  
Anes thes ia occurred immediately , the mice were laid on their s id es and the 
duration of anes thes ia in each animal was quantitated . Awakening was de-
f ined as the time of return of the righting reflex .  (To b e  cons id ered 
awake , each mouse  had to right itself three times in 10 sec . )  
Beginning the next day , the control and diabetic mice wer e in-
2 6  
j ec ted with phenobarbital sodium each day f or f ive cons ecu t ive days a t  6 0  
( 1 s t  day) , 8 0  ( 2nd day ,  etc . ) ,  100 , 100 and 100 mg/kg i . p .  The f o llowing 
day , 100 mg/kg hexobarbital sodium was again adminis tered i . v .  and the 
duration of anes thesia ( l fpos t-phenobarbitall f )  determined . A nonpaired 
S tudent ' s  t- tes t was used to determine the level of s ignif icant differ­
enc es between the pre- and pos t-phenobarbital durations of anes the s ia in 
each pr etreatment group vs control , and the pre- and pos t-phenobar b i tal 
durations of  anes thesia within each pretreatment group . A paired S tud ent ' s  
t-tes t was us ed to compar e  the effects of phenobarbital pretrea tment among 
pretrea tment groups . 
IV . Analyses of Biochemical Changes Induced by Pretr eatments 
A. Glucos e  Level Determinations in Whole Blood or Serum 
Two methods were used . Bo th are free from interf erence by 
sugar s o ther than gluco s e . BGL ' s were determined when s creening for d ia­
b etes (> 250 mg/dl glucose  in STZ- treated mice )  s inc e this method is eco­
nomical but only s emi-quantitative . For precise determinations , s erum 
glucos e  levels ( SGL ' s )  were tes ted . 
1 .  BGL ' s were determined by a tes t-s tr ip glucose-oxidase (GO)  
method (DextrostixR, Ames Co . , Elkhart ,  Indiana) . Animals wer e p laced 
under light ether anes thesia , and 50-60 ul of  blood was drawn into a 
cap illary pipet ins er ted into the animal ' s  retro-orbital s inu s . A larg e  
drop was placed over the entire reagent ar ea o n  a tes t s tr ip . Exac tly 60 
s ec la ter , the blood was washed o f f  with a s tr eam of water . A s emiquanti­
tative (wi thin 25  mg/dl up to 175 mg/dl , or s imply > 250 mg /dl ) measurement 
was made by compar ing the color of the tes t s tr ip wi th a s tandard c olor 
chart . 
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2 .  SGL ' s were determined by the hexokinase (HK) method (General 
Diagno s tics Gluco Strat e ,  General Diagnos tics , Morris  Plains , NJ ) . Blood 
was collec ted as des cribed above and evacuated into a 250  ul c·entr ifuge 
tube , allowed to clot for 10 min , centrifuged , and the supernatant s erum 
u s ed for the as say . Ten ul of  serum was added to 0 . 5 ml of  enzyme r eagent 
containing > 0 . 3 2  I . U .  of  HK, > 0 . 06 I . U .  of  G- 6-PDH , 0 . 7 5  M ATP , 0 . 2  uM 
NADP , 2 5  uM Mg++, tris buf f er ,  EDTA,  protein and methylparaben . S amples 
were p laced in a 3 7 ° C  water-bath and preincubated for 3 minutes . One 
hundr ed ul of color develop er containing 50 mg PMS , 200 mg INT and 
me thylparaben was added to the samp les . The tubes were vortexed , and then 
incubated at 3 7 ° C  f or 10 min . Diluent ( 2 . 5  ml of 0 . 1 N HCl)  was add ed 
f orcib ly . The tubes were vortexed , and the optical densi ty of each s am-
p Ie was determined at 500  nm in a Bausch and Lomb Spec tronic 20 spectro-
pho tometer . Glucose levels (mg/dl)  were calculated from s imul taneous ly 
run s tandards . Calibration curves retained lineari ty through 400 mg/dl  
(data not  shown) . The reactions involved wer e as follows : 
Glucose + ATP 
G- 6-P + NADP 
NADPH + PMS 
PMSH + INT 
HK 
Mg++ ) ADP + G- 6-P 
G- 6-PDH ) 6-PGA + NADPH 
)0 NADP + PMSH 
'> PMS + INTH (red formazan) 
S imul taneous ly drawn and proces sed blood and s erum samp les from c ontrol  
and diabetic mice tes ted for  their glucose  levels verif ied the reliab il i ty 
o f  the test-str ip method (data not shown) . 
B .  Glucose Level Determinations in Brain 
Changes in BGL could alter the levels of glucose  in the brain , 
which , in turn, could af fect respons es to centrally-active pharmaco logic 
agents .  The method of  Lowry et al . ( 1 9 6 4 )  wi th the modifications described 
by King et a1 . ( 1 9 7 7 )  was used to quantitate brain glucose  levels . At 
the appropr iate time af ter pretreatment , mice were p lunged into liquid 
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NZ (-150 ° C )  and agitated vigorously for 1 min to facilitate rapid freezing . 
About 100 mg of cortex · was removed in a co ld chamber at -ZO ° C  to preven t  
thawing . Fro zen animals and dissec ted cor tices were kep t at -80 ° C ,  ex-
cep t  for the few minutes necessary for dissec tion . The cor tex was powder-
ed 1n a mor tar chilled in liquid NZ . The p owder was added to a tube con-
taining 0 . 3  m1 of 3 M HC104 and agitated until the acid had completely 
p ene tra ted the powder and r emoved the HZO ( 3  to 5 min) . To each samp le 
was added 1 . Z5 m1 of  1 mM EDTA in HZO , and af ter mixing at 4-5 ° C  for 10 
min , the tubes were centr ifuged , and 1 m1 of  supernatant was mixed wi th 
0 ; 33 m1 of  Z M KHC03 . The pH of  the solution was adj usted to between 7 . 5  
and 8 . 0  by the addition of  approximately Z5  u1 of  Z M Tris bas e . S amples 
wer e kep t at -80 ° C  until they were analy zed f or their glucose levels .  
The determination of glucose levels in brain was s imilar to  the 
d e termina tion of SGL ' s (HK method ) , excep t that the f inal reaction yielded 
a f luores cent material measur ed in an Aminco spec trof1uorometer ( Lowry e t  
a 1 . , 1964) . Br ain glucose  levels were interpo lated from a curve generated 
by adding known amounts o f  glucose  to the extraction reagents ,  and a s s ay ed 
s imultaneously wi th the brain samples . Statis t ical compar is ons o f  brain 
glucos e  levels in pretrea tment groups vs control were made by S tudent ' s  
t-tes t .  
C .  Insulin Level Determinations in Serum 
Sugar-induced hyperglycemia , insulin inj ection or diabetes  could 
affect serum insulin levels , disrup ting the body ' s metabolic prof ile , and 
af f ec t ing respons es to drugs . A mod if ication of the 1Z5Iod ine ( lZ 5 I )  
rad io immunoassay technique of Mor gan and Lazarow ( 1963 ) was used to  d e-
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termine the concentration of  immunoreac t ive insulin ( IRI ) in s erum sam-
p Ies o f  mice from the various pretr eatment group s . 
1 .  Pr eparation of  columns and equilibrating solution . Iso tonic 
s al ine was poured on dry sephadex G25 and G7 5 ( in s eparate ves sels ) and 
lef t to equilibrate overnight . Burettes ( 2 5  ml )  were cut o f f  at  the 11 
ml mark and the bo ttoms packed with glass  wool . With 2-5 ml of  saline 
alr eady added to the burettes , the gel-saline mixtur e was poured int o  the 
c olumns with the s topcock open .  The gel was thus packed at the liquid 
f low rate . The dimens ions of  the packed co lumns were  1 x 12  cm . The G 2 5  
c o lumn was used j us t  af ter the iod ination o f  the insulin tracer for the 
f f d O l o  b d 125 1 d ° b  d b 1 s eparation 0 ree an �nsu �n- oun as escr� e e ow . The G7 5 
co lumn was used before the actual as s ay was performed to s eparate damag ed 
( impure) tracer from the usable tracer as described below . Before us e ,  
b o th co lumns were equilibrated with a modif ied phosphate buf f er with the 
f ollowing cons tituents :  36 g sod ium chlorid e (NaCl ) , 11 . 88  g anhydrous 
d ibasic sod ium phosphate , 3 . 48 g mono-basic sodium phosphate , 0 . 4  g 
thimero sal , and 8 . 0  g albumin , which wer e dis solved in 2000 ml H2 0 ,  and 
then water was added to make 4000 mI . The f inal solution was equivalent 
to 0 . 0 2 5  M phosphate buf f er with 0 . 9 %  NaCl , 0 . 1% thimerosal and 0 . 2 % 
a l bumin . (Al l pho s pha t e  buf fers were a t  a pH o f  7 . 5 . ) 
2 .  Diluting f luid pr eparation . Equilibrating solution ( 10 0  ml) 
was add ed to 0 . 8 g albumin ( increasing the albumin content to 1 . 0 % ) . This  
solution was used to dilute all unknowns , to formulate s tandards , and to  
dilute the tr acer . 
3 .  Brom-phenol blue- s tained diluting fluid preparation . F if teen 
mg o f  brom-phenol b lue was add ed to 100 ml of diluting fluid . This was 
used as a marker on the columns s ince it  is eluted coincidentally with the 
crude l25 I- insulin tracer and j us t  prior to pur if ied , usable tracer . 
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4 .  Production of  anti- sera I .  One-half ml of isotonic ( 0 . 9 % )  
s aline was added t o  0 . 5 m g  of  pork insulin (Lilly) : an equal vo lume o f  the 
insulin solution was added to complete Freund ' s  adj uvant (Difco ) . The 
adj uvant- insulin mixture was emulsif ied by repeatedly being drawn into a 
2 0  gauge needle attached to a syringe . Guinea pigs were immuni z ed by the 
s . c '. inj ec tion of 2 mg insulin ( in the adj uvant- insulin emulsion)  every 
3 weeks . Ten days af ter the third inj ec tion , the guinea pigs were ex-
s anguina ted by cardiac punc tur e .  The blood was allowed to c lo t  for  10 
min,  c entrifuged , and the sup ernatant s erum s tored at -80 ° C  until us e .  
5 .  Anti-Sera II . This was purchased from Arnel Laboratories . 
It contains rabb it antibodies to guinea pig s era . It was diluted 1 : 2  
with the diluting f luid descr ibed in Sec tion 2 ,  and l2 . S  mg /ml EDTA was 
added as a pres ervative . 
6 .  125 1 d "  " f "  I "  o 1nat10n 0 1nsu 1n tracer . A modif ication of  the 
l 2 S  method of Gr eenwood et al . ( 1 9 6 3 )  was used to prepare the I insulin 
tracer . 
Sodium l 2 SIodide  (Na
12 S I )  was purchased from Amer sham Corp . 
( s p ec if ic activity 1 mCi in 0 . 1  ml ) . Fif ty ul of 0 . 1 mg/ml pork insulin 
in 0 . 05  M phosphate buf f er , 20 ul of 0 . 5 M pho sphate buf f er .  and 2 0  ul of  
1 mg /ml chloramine-T in  0 . 05 M phosphate buf f er was added to  the l 2 SI • 
Eleven to 13 sec later 20 ul of S mg/ml sodium metabisulf ite in O . OS M 
phosphate buf fer , SO ul of  50 mg /ml po tas s ium iod ide in O . OS M phosphate  
buf f er and 50 ul  of the brom-phenol blue s tained albumin solu tion were 
added . Two hundred ul of the resulting mixture were put on the s ephad ex 
G25 c olumn and collected in 1 ml fractions . Us e.ab le tracer was eluted c o inc i-
dent with the blue dye .  
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7 P · f · . f d 125 1 .  1 ·  • ur � �cat�on 0 cru e - �nsu �n . Fif ty ul of  the br om-
pheno l blue s tained albumin , 7 5  ul of the crude tracer and enough normal 
guinea pig sera to yield a to tal volume of 210 ul wer e put in a small t es t  
tub e .  This mixture was incubated a t  4 ° C  for 2 4  hours . 200 ul of the mix-
tur e was placed on the sephadex G7 5 column and 1 ml fractions were col-
l ec ted . Us eable ,  pur if ied tracer was eluted in the f ir s t  2 ml af t er 
elution of the blue dye . 
8 .  Pr eparations of insulin s tandard s .  Crys talline p ork insul in , 
assayed at 25 . 9 U/mg was used to prepare s tandard solutions . A s tock 
solut ion containing 500 uU/ml in diluting fluid was pr epar ed . Working 
s tandards of 160 , 1 2 0 , 80 , 40 and 10 uU/ml were prepared from the s tock 
solution . 
9 .  Insulin rad ioimmunoas say .  This procedure is a modif ica tion 
o f  the method of Morgan and Lazarow ( 1 9 63 ) . The following tubes were s e t  
up : Blank ( tr iplicate) cons is ting of  2 0 0  u l  diluting fluid and 5 0  u l  
tracer ; Anti-sera Blank ( tr iplicate) containing 100 u l  diluting f luid , 5 0  
ul tracer and 1 0 0  u l  anti-sera I ; Standards ( tr ip licate)  containing 100 u l  
insulin s tandard , 50 u l  tracer and 1 0 0  u l  anti- sera  I ; and unknown s era 
( 6  s amp les / pretreatment in duplicate) cons isting of 100 ul of  s erum (which 
was d iluted 1 : 2 ,  1 : 3 or 1 : 4  so  insulin conc entration is < 160 uU/ml ) , 5 0  
u 1  tracer and 100 u l  anti-s era I .  All tubes were incubated f or 2 days at  
4 ° C .  100 ul o f  anti- sera I I  was added t o  each tub e . All tubes were 
then incubated at 4 ° C  f or one additional day . Tubes were then c entrifuged 
at 4 ° C ,  3000 rpm for 20 min , and the supernatant aspirated and dis carded . 
125  The p r ec ipitates ( c ontaining antibody-bound Insulin) wer e resuspended 
and washed with 0 . 3 ml of cold equilibrating solution . Following centr i-
fugat ion at 4 ° C ,  3000 rpm for 20 min , the washing fluid was aspirated and 
discarded . The tubes were placed in counting tubes , and counted in a 
Gamma c ounter for 5 minutes . The number of cpm recorded by the counter 
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f or the s tandard s  and unknowns , was used t o  calculate the % bound immuno-
reac t ive insulin ( IRI) as : 
% bound IRI 
cpm in s tandard or unknown 
= cpm in anti-sera blank ( 100% bound ) x 100 
A s tandard curve of  % bound IRI vs insulin (uU/ml ) was prepared and the 
ac tual insulin conc entrations in unknown samp les wer e determined by inter-
polation from the curve . Signif icant differences in serum insulin l ev el s  
from pretreatment groups vs  control were d e termined by  S tudent ' s  t-tes t .  
D .  Brain Water Content and Serum Osmolar ity 
The hyperglycemia caused by d iabe tes could increase s erum o smol-
ari ty suf f iciently to induc e  d ehydrat ion of the brain , altering drug d is -
tribution in the brain . 
1 .  Brain water content . Mice  were d ecapitated , and their brains 
r emov ed , cleansed of adherant blood , blo tted and weighed . They wer e then 
p laced in an oven and dried to a cons tant weight ( overnight ) .  The next 
morning they were weighed again , and the % H20 by weight was calculated as : 
We t Weight - D�y weight 
x 100 = % H 0 Wet we�ght 2 
2 .  S erum o smolar i ty .  Trunk blood was c ol l e c t ed into c entr ifuge 
tubes from 6 mice f o llowing decapitation and allowed to clot  for 10 min3 • 
The tubes wer e centrifuged and the supernatant serum transf erred into 
smaller s toppered tubes . Serum o smolar ity was then determined in a 
Precision Sc ientific osmometer by comparing s erum freezing point with 
3
The assump tion is being made that changes in the osmolar ity of the 
combination of serum and o ther tissue fluids obtained by decap itation re­
f lect changes in serum alone . 
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s tandard solutions of known osmolarity . Values were express ed as m Osmolar 
U/ kg s erum . S tatis tically s ignif icant d if f erences in brain water c ontent 
or s erum osmo larity were determined by S tudent ' s  t-tes t .  
RESULTS 
I .  General 
A.  Strepto zotocin- Induced Diabetes in Swiss  Mice 
1 .  Body weight . Inj ection of  STZ ( 200  mg/ kg i . v . ) in randomly 
s elec t ed mice caused a promp t , marked weight loss (Figure 1 ) . Mean body 
weights decreased from a pre-STZ mean of  24 . 9  g t o  19 . 3  g (p  < 0 . 0 5 )  with­
in one week of the inj ection . This  weight loss d id no t appear to result 
from decreased f ood consump tion , but could have b een due to incr eas ed 
water loss . These animals d id no t gain s ignif icant amounts of  weight unt i l  
5 weeks after the inj ec tion . Although the mice continued to gain weight 
throughout the res t of the 18 week observation period , and eventually r e­
turned to their pre-inj ection weights ,  their body weights never c aught up 
to thos e  of the control group , and hyperglycemia persis ted throughout the 
18 week obs ervation per iod . 
2 .  Survival . The effects of a s ingle i . v .  dose of  STZ ( 200  mg/ 
kg) on the animals ' survival is shown in Table 1 .  Three days af ter the 
inj ection of STZ into nine mice , one died . No o ther deaths occurred in 
the d iabetic animals until week nine , when one add i tional mouse d i ed . 
Necrops ies revealed no gross  patholo gic s igns . Dur ing the rout ine prep­
aration of STZ-diabetic animals , throughout the entire research proj e c t , 
i t  was observed that when deaths occurred following STZ inj ec tion , they 
occurr ed during days 2-4 following inj ec tion and at approximately the same 
rate (1  dead / 10 inj ec ted ) . For this r eason no exper iment was begun less  
than 6 days following STZ inj ec tion , the per iod af ter which any d eaths 
would occur (until s everal weeks later ) and during which the animals ' los s  
o f  weight was greates t .  No mor ibund animals were observed on the experi-
34 
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Figure 1 
The effects  of  a s ingle inj ection of  S treptozotocin ( STZ)  at 200 mg/kg i . v .  
on body weights in randomly s elected f emale mice . Control mice received 
vehicle only . At each time point � n >  7 .  S erum glucose  levels (X + S . E . )  
are shown in parentheses at each time point along the STZ curve . 
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Table 1 
Comparison of Survival in Strep to zotocin ( STZ) -Induced 
Diabetic Mic e  with Vehic le-Inj ected Control Mice 
Pretreatment 
Weeks Af t er STZ or Vehicle 
0 1 2 5 9 13 18  
Vehicl e  Control 
Number Surviving/ 
Number Inj ected 10/10 10 / 10 10 / 10 10/ 10 10 / 10 10/ 10 1 0 / 10 
% Surviving 100 100 100 100 100 100 100 
STZ 20  mg/kg i .  v .  
Number Surviving/ 
Number Inj ected 9 / 9  8 / 9  8 / 9  8 / 9  7 / 9  7 / 9  7 / 9 
% Surviving 100 88 . 9  88 . 9  88 . 9  7 7 . 9  7 7  . 8  7 7  . 8  
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mental days . 
I I . Narco tic Induced Antinocicep tion and Related S tudies 
A. Ta il-Flick 
1 .  Swiss mic e .  General obs ervations . The pretrea tment group 
that was fasted and then received insulin s . c .  was lethargic and hypo s en-
s it ive to touch . No behavioral changes wer e  obs erved in any of  the o ther 
pretreatment groups nor did any of  the various pretreatments have a s ig-
nif icant ef f ec t  on tail-flick latency . 
a .  Morphine . In a pilo t set  of experiments , a s ingle d o s e  
o f  morphine ( 5  mg /kg s . c . ) was administer ed to mice with various pre-
treatment s ,  and the increase  in tail f lick latency was compared wi th con-
trol mice . In experiments  with S TZ- induced diabetic mice and dextros e­
pretr ea ted mice (both caus ing hyper glycemia) 4 s ignif icantly attenuated 
responses to morphine in the tail-f lick test  were observed compared with 
contro l  mice ( Table 2 ) . Pr etr eatment with 1 U/kg insulin following an 18 
hr fast ( suff icient to cause hypoglycemia) signif icantly po tentiated the 
antino c icep tive effects of  morphine (3 mg/kg s . c . )  compared to contr o l  
mice ( Table 3 ) . Subs equently , log-dos e-respons e curves were generated 
f or the effects  of  morphine in the tail-flick tes t using each o f  the fol-
lowing pr etreatment group s : c ontrol ; STZ-induc ed diabetic ; STZ-diab etic 
and insulin ; dextrose ; fas t ed ; and fas ted and insulin . In each case , 
there was an inver s e  relationship between morphine potency and s erum glu-
cose  levels ( SGL ' s )  r eported in Tab le 24 . The potency ratio s vs contro l  
were s ignif icantly dif f erent for all pretr eatment group s excep t the fas ted 
4Alterations in BGL produced by the various pretreatment s  are pre­
s ented on page 73 . 
Table 2 
Ef f ec t  of Streptozotocin ( STZ) - Induc ed Diabetes or Pretreatment wi th Dextrose on the Ant inoc icep t ive 
Act ion o f  a S ingle Dos e  o f  Morphinea Compared with Control Mice as 
Quantitated in the Mous e  Tail-Flick Tes t 
Baseline 
b 
Tes t b Difference 
Pretreatment React ion (sec)  React ion ( sec ) ( s ec ) b 
Control 2 . 83 ± 0 . 15 9 . 7 3 ± 0 . 27 6 . 90 ± 0 . 31 
STZ
d 3 . 08 ± 0 . 18 6 . 13 ± 0 . 90 3 . 05 ± 0 . 92 
Control 3 . 16 ± 0 . 14 9 . 04 ± 0 . 4 9 5 . 88 ± 0 . 5 1 
Dextr ose e 2 . 7 7 ± 0 . 14 5 . 98 ± 0 . 83 3 . 21 ± 0 . 83 
a Morphine 5 mg/kg ( s . c . ) 20 minutes prior to Tes t React ion determinat ion 
b -X ± S . E . , n = 12 
c S tudent ' s  t-tes t 
d 
200 mg/kg i . v .  6 days earlier 
e 0 . 028 mol /kg i . p .  25 min bef ore morphine 
c Level o f  Signif icance 
p < 
0 . 001 
0 . 001 
w 
ex> 
Table 3 
Ef f ec t  of Fas ting + Insulin Pretr eatment on the Antinocicep tive Act ion 
of  a S ingle Do s e  of Morphinea Compared with Control Mice 
as Quantitated in the Mous e  Tail-Flick Tes t 
Pretr eatment (n) 
Control (12)  
Fas ting + 
Insu1inC ( 13 )  
Baseline 
b Reac t ion ( s ec )  
2 . 7 5  ± 0 . 15 
2 . 9 5 ± 0 . 13 
Tes t 
b React ion ( s ec)  
4 . 6 2 ± 0 . 60 
8 . 08 ± 0 . 6 5 
Dif f er ence 
( s e c ) b 
1 . 8 6 ± 0 . 60 
5 . 13 ± 0 . 7 0d 
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a Morphine 3 mg /kg ( s . c . ) 20  minutes prior to Tes t Reaction determinat ion 
b -
X ± S . E . 
c 18  hr fast + insulin 1 U/kg s . c .  20  min before morphine 
d p < 0 . 005 vs control group difference using S tudent ' s t-test 
40 
group . The data from this exper iment are presented in Table 4 .  Both the 
d extr o s e-pretreated and STZ- induced diabetic mice  (both group s were hyp er­
g lycemic )  were s ignif icantly les s s ens itive to the antinocicep tive ef f ec t s  
o f  morphine , suggest ing that the hyperglycemia caused the altered s ens i­
t ivity . Insulin tr eatment ( 3  U/kg s . c . ) of  o ther STZ-induced d iabetic 
mice lower ed serum glucos e  levels and returned the s ens itivity to  morphine 
to normal . However , the d iabetic animals adminis t ered insulin were not 
the s ame mice as tho s e  which wer e  t e s t ed without insulin . In another ex­
p er iment the potency of morphine was tes ted us ing the same STZ-diab e t i c  
m i c e  with and without insulin inj ec tions o n  separate days . On day 1 ,  they 
wer e administer ed morphine but no t adminis t er ed insulin and t es ted in the 
t ail-flick assay .  Af ter a four day res t  (day 5 ) , they were tes ted in the 
tail- f lick test again, but were inj ec ted with 3 U/kg insulin s . c .  20 min 
pr ior to morphine . Thes e  results  are presented in Table 5 .  On day 1 ,  
the STZ-diabetic mice were s ignif icantly less s ensi t ive to morphine than 
the control mice,  but on day 5 when administered 3 U/kg insulin 20  min 
before morphine , the diabetic animals ' s ens itivity to morphine ' s ant ino­
c ic ep t ive eff ec t  returned to normal . Thus the effects  of STZ-induc ed 
d iabet es  on morphine potency are revers ible by insulin adminis tration . 
Insulin- induced hypo glycemia in fas t ed mice caus ed a s ignif icant increas e  
i n  morphine potency ( Table 4 ) . 
The ef fects of  pretreatment with fruc tose  or 3-0-methy1g1u­
cos e  (a non-metabolizable sugar ) on morphine-induced antinocicep tion wer e  
d e t ermined in an attempt to elucidate the mechanism of  how STZ-diab e t es 
alter ed morphine potency . Pr etreatment with 3-0-methy1 glucose  did no t 
have a signif icant ef fec t on morphine potency wher eas pretreatment with 
f ruct o s e  s ignificantly decreased s ens itivity to  morppine (Tab le 6 ) . This 
Table 4 
Ef f ec t  of Various Pretreatments on the ED50  of 
Morphine in the Mouse  Tail- Flick Tes t 
Pretr eatment (n/dose)  
Control ( 3 6 )  
STZc ( 1 2 )  
STZ + Insul ind ( 1 2 )  
e Dextr o s e  ( 1 2 )  
Fas t ing f ( 12 )  
Fas ting + Insuling ( 1 2 )  
a mg/ kg s . c .  
b vs control 
ED50  
a 
2 . 7 3 
3 . 91 
2 . 3 7 
3 . 81 
2 . 6 9 
1 . 87 
Potent? 
Rat io 
1 . 00 
0 . 7 0h 
1 . 17 
O . 7 2h 
1 . 02 
1 . 4 7h 
9 5 %  
Conf idence Limit s  
of  Potency Rat io 
0 . 5 3 - 0 . 93 
0 . 6 7 - 2 . 02 
0 . 58 - 0 . 8 9 
0 . 88 - 1 . 17 
1 .  08 - 1 .  9 9  
c 2 0 0  mg /kg S treptozotocin ( STZ ) i . v .  6 days earlier 
d 200 mg /kg STZ i . v .  6 days earlier + 3 U/kg insulin s . c .  20 min before 
morphine 
e 0 . 0 2 8  mol/kg i . p .  25 min before morphine 
f 18 hr befor e morphine 
g 18 hr fas t + 1 U/kg insulin s . c . 20 min before morphine 
h p < 0 . 05 vs control ( Barr et al . ,  19 7 6 )  
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Table S 
Return to Normal of Sensitivity to Morphine in Strep tozotocin 
( STZ ) - Induced Diabetic Mic e  by Treatment with 
Insulin in the Tail-Flick Tes t  
Day Pretreatment EDSO 
a 
Control 2 . 94 
1 STZ
c 6 . 21 
S STZ + Insulind , e 1 . 61 
a mg / kg s . c . , n = 6 /dose  of  morphine 
b vs control 
c 200 mg /kg i . v .  6 days earlier 
d same animals as Day 1 STZ 
P o t ency 
Rat iob 
1 . 00 
0 . S6 f 
1 . 83 
9 S %  
Conf idence Limit s  
of  Potency Ratio 
0 . 34 - 0 . 91 
0 . 8 8 - 3 . 7 3 
e 200 mg/kg STZ i . v .  10 days earlier + 3 D / kg insulin s . c .  20 min before  
morphine 
f p < O . OS vs control ( Barr et al . ,  197 6 )  
4 2  
Table 6 
Ef fect of Fructose or 3-0-Methy1 Gluco s e  Pr etr eatment on the 
EDSO of Morphine in the Mous e  Tail- Flick Tes t 
Pretreatment EDS O 
a 
Contro l  4 . 38 
Fructose  c 15 . 4  
3-0-methy1 glucose c 3 . 90 
a mg/kg s . c . , n = 6 /dose of  morphine 
b vs c ontrol 
c 0 . 0 2 8  mol/kg i . p .  20  min before morphine 
d p < 0 . 05 vs control ( Barr et a1 . ,  197 6 )  
Potency 
Rat iob 
1 . 00 
0 . 28d 
1 . 12 
9 5 %  C . L . o f  
Potency Ratio 
0 . 15 - 0 . 53 
0 . 56 - 2 . 23 
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decrease in morphine potency caused by  fruc tose  pretr eatment was more 
marked than that caused by d extrose  pretreatment . It was f ound (data not 
shown) that an inj ect ion of  insulin ( 5  U/kg s . c . ) 15 min prior t o  the ad­
minis tration of dextrose could prevent the occurranc e of hyper glycemia . 
This regimen was also found to r eturn the sens itivity to morphine t o  c on­
trol  levels (Table 7 ) . When this same insulin treatment was adminis t ered 
t o  mice  pretreated with fructose ,  these animals ' s ens itivity to morphine 
was s till significantly lower than controls , but also s ignif icantly greater 
than with fructose alone . 
The next question to be answered was whether the eff ec t  o f  
these pretreatments o n  morphine potency would also af f ec t  the potency o f  
o ther narco tic analges ic s . 
b .  Phenazocine . The eff ec t s  of  various pretreatment s  admin­
ister ed to Swiss  mice on the antinocicep t ive potency of phenazo c ine are 
shown in Table 8 .  Without excep tion , pretreatments that s ignificantly 
alter ed morphine potency (Table 4 )  also s ignif icantly changed the p o t ency 
of phenazocine in the same d ir ec tion . The potency ratio f or each pre­
treatment group tested vs control  for phenazocine was s imilar to that f or 
morphine. 
c .  Levorphanol .  The various pretreatments adminis ter ed 
caus ed changes in the antinoc icep t ive potency of levorphanol s imilar to  
tho se seen with morphine and phenazocine with the exception of the group 
that was fasted and adminis t ered insulin (Table 9 ) . In this group , the 
9 5% conf idence limits of  the potency ratio j us t  included 1 . 00 .  Thi s  indi­
cates that the fasted + insulin pretreatment group is no t signi f icantly 
more sens itive to levorphanol than the control group , although it i s  mor e  
s ens i t ive t o  morphine and phenazocine . 
Table 7 
Ef f ec t  of Insulin in Rever s ing the Decreas ed Potency of Morphine in 
Mice  Pr etreated with Dextrose or Fruc tose in the Tail-Flick Tes t 
Pretreatment ED50 
a 
Contro l  3 . 31 
Dextr o s e  c 5 . 40 
Insulin + Dextrose d 3 . 13 
Fruct o s e  c 18 . 94  
Insul in + Fructos e d 9 . 02 
a mg/kg s . c . ,  n = 6 /dose of morphine 
b vs control 
Pot ency 
Ratiob 
1 . 00 
0 . 61e 
1 . 05 
0 . 17
e 
0 . 3 7 e , f 
c 0 . 0 2 8  mol/kg i . p .  25  min before morphine 
9 5 %  
Conf idence Limit s  
of  Potency Rat io 
0 . 4 9 - 0 . 7 8 
0 . 85 - 1 . 3 1  
0 . 14 - 0 . 22 
0 . 29 - 0 . 46 
d 5 U/kg insulin s . c .  15  min before d extrose or fruc tose + 0 . 0 2 8  mol / kg 
dextrose or fructose 25  min before morphine 
e p < 0 . 05 vs control ( Barr et a1 . ,  197 6 )  
f p < 0 . 05 vs fructose ( Barr et a1 . ,  197 6 )  
4 5  
Table 8 
Ef f ec t  of Various Pretreatments on the EDSO of Phenazocine 
Pretreatment (n) 
Contro l ( 1 2 )  
STZc ( 6 )  
Dextrose  d (12 ) 
Fas t inge ( 6 )  
Fas ting + Insulin 
a mg/ kg s . c . 
b vs c ontrol 
f 
in the Mous e  Tail-Flick Tes t 
Potency 
EDSO 
a Ratiob 
0 . 25 1 . 00 
0 . 38 0 . 6 Sg 
0 . 46 0 . 67 g 
0 . 22 1 . 12 
( 6 )  0 . 10 2 . 4 9g 
c 200  mg /kg S treptozotocin ( STZ ) i . v .  10  days earlier 
d 0 . 028  mol/kg i . p .  2S min before phenazocine 
e 18 hr before phenazocine 
9 S % 
Conf id ence 
of  Potency 
0 . 4S -
O . S O -
0 . 7 9 -
1 .  74  -
f 18 hr fast  + 1 U/kg insulin s . c .  2 0  min before phenazocine 
g p < O . OS vs control ( Barr et al . , 1 9 7 6 )  
4 6  
Limit s  
Rat io 
0 . 94 
0 . 90 
1 . 61 
3 . S 6 
Table 9 
Ef f ec t  of Var ious Pretrea tments on the ED5 0  of  Levorphano1 
in the Mous e  Tail-Flick Tes t 
a Potency Pretreatment (n/dos e )  ED50  Rat io
b 
Contro l  ( 1 2 )  0 . 65 1 . 00 
STZc ( 6 )  1 . 03 0 . 63
g 
Dextr o s e  
d ( 6 )  1 . 08 0 . 61
g 
Fas tinge ( 8 )  0 . 45 1 . 44 
Fas ting + Insu1inf ( 6 )  0 . 4 2 1 . 5 7 
a mg/kg s . c .  
b vs c ontrol 
c 200  mg /kg Strep tozotocin ( ST2 ) i . v .  8 days earlier 
d 0 . 0 2 8  mol/kg i . p .  25 min before 1evorphano1 
e 18 hr fas t  before 1evorphano1 
95 %  
Conf idence Limit s  
of  Potency Ratio 
0 . 4 1 - 0 . 98 
0 . 3 9 - 0 . 9 5 
0 . 93 - 2 . 24 
1 . 00 - 2 . 4 9 
f 18 hr fast + 1 U/kg insulin s . c .  20  min before 1evorphano1 
g p < 0 . 05 vs control ( Barr et a1 . ,  197 6 )  
4 7  
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d .  Methadone . None of the var ious pretreatments adminis t er­
ed had a signif icant ef fect on the antinociceptive ef fect  of  methadone in 
the tail-flick test ( Table 10) . This provided an indication that STZ­
induc ed d iabetes or the o ther pretr ea tments does no t alter the potency of  
all narco tics . 
e .  Propoxyphene . Like methadone , the antinocicep t ive po­
tency o f  propoxyphene was no t s ignif icantly altered in STZ-induc ed dia­
b etic mice or in mice with various o ther pretrea tments (Tab le 11) . But 
because propoxyphene is s truc turally s imilar to methadone , it  was decided 
to tes t a narco tic s tructurally d i s s imilar to tho s e  previous ly tes t ed . 
f .  Meperidine . The antinocicep tive potency of mep eridine 
was no t significantly changed by any of the pretr eatments as shown in 
Table 1 2 .  
I t  thus appear s that the various pretreatments can alter the 
s ens i tivity of mice to some narcotics , but not all , as measured in the 
tail- f lick tes t .  Morphine was s elec ted a s  the pro t o type narcotic t o  b e  
used in all subsequent exper iments . 
2 .  Rat s .  In an attemp t to determine whether the ef f e c t s  on 
morphine antinocicep tion seen in Swiss  mice  with STZ-induc ed d iabetes 
occurred in o ther species , the anticocic ep tive potency of morphine was 
evaluated in control vs S TZ- induced diabetic rats . The data from this ex­
p er iment are presented in Figur e 2 .  As was the case with STZ-induc ed d ia­
betic mic e ,  the diabetic rats were s ignif icantly less sens i t ive to the 
antino c icep tive effects of morphine as measured by the tail-flick tes t .  
The ED50
' s for morphine wer e 4 . 6 and 8 . 4  mg /kg in control and STZ-induced 
d iabetic rats , respec t ively . The analysis of  covariance procedure d e ter­
mined a potency ratio of 0 . 54 ,  with 9 5 % conf idence limits of 0 . 40 to 0 . 7 4 ,  
Table 10 
Ef fec t  of  Various Pretreatments on the ED50  of  Methadone 
in the Mouse Tail-Flick Tes t 
4 9  
9 5 %  
Pretreatment ED5 0  
a Potency Ratiob 
Conf idence Limit s  
of  Potency Ratio 
Control 2 . 4 2 
STZc 2 . 7 2 
Dextro s e  d 2 . 48 
Fas ting e 2 . 35 
Fas t ing + Insulin f 2 . 3 6  
a mg /kg s . c . , n = 6 / dose o f  methadone 
b vs c ontrol (Barr et al . , 197 6 )  
1 . 00 
0 . 8 9 
0 . 9 8 
1 . 03 
1 . 03 
c 200 mg/kg S trep tozotocin ( ST Z )  i . v .  6 days earlier 
d 0 . 028  mol/kg i . p .  25 min before methadone 
e 18 hr fas t  before methadone 
f 18 hr fast + 1 U/kg insulin s . c .  20 min before me thadone 
0 . 57 - 1 .  7 6  
0 . 68 - 1 . 4 2 
0 . 7 1 - 1 . 5 0 
0 . 7 1 - 1 . 49 
so 
Table 11 
Ef f ec t  of Var ious Pretreatments on the EDSO o f  Propoxyphene 
in the Mouse Tail-Flick Tes t 
Pretreatment EDSO 
a 
Contro l  12 . 4  
STZc 12 . 2  
Dextrose  d 12 . 7  
Fas ting e 12 . 3  
Fas ting + Insulin f 12 . 1  
a mg/kg , n = 6 / dos e  of  propoxyphene 
b vs control (Barr et a1 . , 1 9 7 6 )  
Potency 
Rat iob 
1 . 00 
1 . 02 
0 . 9 8 
1 . 01 
1 . 02 
c 200 mg/kg Str eptozotocin ( STZ ) i . v .  8 days earlier 
d 0 . 0 2 8  mol/kg i . p .  2S min before propoxyphene 
e 18 hr fas t befor e propoxyphene 
9 S %  
Conf idence Limit s  
of Potency Rat io 
0 . 67 - 1 . S4 
0 . 64 - 1 .  4 8  
0 . 6 6 - 1 . S1 
0 . 6 7 - 1 . S4 
f 18 hr fas t  + 1 U/kg insulin s . c .  20 min before propoxyphene 
Table 12  
Ef f ec t  of Various Pr etreatments on the ED5 0  of  Meperidine 
in the Mouse Tail-Fl ick Test 
Potency 
Pretr eatment (n/dose)  ED50 
a Ratiob 
Contro l  ( 12 )  13 . 8  1 . 0 0  
STZc ( 6 )  12 . 1  1 . 14 
Dextr o s e  d ( 6 )  13 . 6  1 . 01 
Fas t inge ( 6 )  10 . 7  1 . 2 9 
Fas ting + Insu1inf ( 6 )  9 . 7 1 . 4 2 
a mg / kg 
b vs control 
c 200 mg/kg Streptozotocin ( STZ ) i . v .  10 days earlier 
d 0 . 028  mol/kg i . p .  25 min before meper idine 
e 18 hr fast before meperid ine 
9 5 %  
Conf idence Limits 
of  Potency Rat io 
0 . 8 1 - 1 .  6 1  
0 . 7 2 - 1 . 4 2 
0 . 87 - 1 . 9 2 
0 . 94 - 2 . l3 
f 18 hr f ast  + 1 U/kg insulin s . c .  20 min before meper idine 
5 1  
5 2  
Figure 2 
The e f f ec t s  of  Streptozotocin ( STZ ) -induced diabetes in rats on the ant i­
nocicep tive potency of  morphine as quantitated in the tail-flick tes t . 
STZ was adminis tered 6 days earlier at  a dose of 60  mg/kg i . v .  The equa­
tions f or both lines were generated by analysis of covariance ( Barr et al . ,  
1 97 6 ) . 
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very s imilar in magnitude to  the results in STZ- induced diabetic Swiss 
mic e .  
3 .  C57Bl/KsJ mic e .  The next attempt was to determine whether 
the d ecrease in morphine ' s  potency seen in STZ-induced diabetic mic e  and 
rats would also be seen using s t ill ano ther animal model of human d iabe tes 
mellitu s . In Table 13 , it can be s een that mice homo zygous f or the gene 
"dbm" (diabetes ) are signif icantly less sens itive to the ant inocicep t ive  
ef f ec ts of morphine sulfate in  the tail-flick tes t , when compar ed with 
mice who are merely heterozygous . The potency ratio between thes e group s 
o f  mice  ( 0 . 0 9 )  is of even greater magnitude than that between STZ-induced 
d iabetic mice and their r es p ec t ive control . This relationship is shown 
in Figure 3 .  The C57Bl/KsJ dbm/++ mice as a group appear to b e  mor e  s en­
s it ive to morphine than the Swiss mice while the spontaneous ly d iabe t i c  
mice (dbm/dbm) are even l e s s  s ensitive to the antinocicep t ive e f f e c t s  of  
morphine than are the STZ- induced d iabetic mic e .  
In summary , STZ- induc ed diabetes and other pretreatments which 
affect  blood glucose levels can aff ec t  the ant inocicep tive potency o f  
morphine, phenazocine and levorphanol ,  but not methad one , propoxyphene o r  
mep er idine . The decreased s ensitivity to morphine seen in STZ-induc ed d ia­
b e t ic mice was also capable of being produced in mice with spontaneous 
d iabetes , STZ-induc ed d iabetic rats , and mice  pretr eated with dextr o s e  or 
fructose while 3-0-methyl glucose pretreatment had no s ignif icant effect  
on morphine potency . The potency of  morphine in STZ-induced d iabetic  and 
d ex trose-pretreated mice was returned to normal by the adminis tration o f  
insulin. Additionally , sever e hypoglycemia rendered mice supers ens i t ive 
to the antinocicept ive ef f ec t s  o f  morphine . Pretreatment of mice  by 
f a s t ing showed only a trend toward s  s ignif icance . 
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Table 13 
The ED50 of  Morphine in Spontaneous ly Diabetic Mice and Their 
Nondiabetic Littermates in the Tail-Flick Tes t 
Genotyp e 
dbm/++ (nondiabetic ) 1 . 5  
dbm/dbm (diabetic)  17 . 2  
a mg/ kg s . c . , n = 6 /dos e of  morphine 
b vs control 
c p < 0 . 05 vs control ( Barr et a1 . ,  1 9 7 6 )  
Potency 
Rat iob 
1 . 00 
0 . 09 c 
9 5 %  
Conf idence L imit s  
of  Potency Rat io 
0 . 04 - 0 . 20 
5 5  
Figure 3 
Compar ison of the sensitivity to morphine shown by mic e  wi th diff erent 
models of human diabetes mellitus and their respec tive controls u s ing the 
tail-flick test . STZ = S treptozotocin 200  mg/kg i . v .  6 days earlier . 
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B .  Phenylquinone-Induced Wr ithing 
To verify that the ef f ec t s  seen in the tail- flick tes t c omparing 
STZ- induc ed diabetic mice with control mice in their respons e to morphine 
was no t peculiar to j us t  the tail-flick ref lex response , the phenylquinone 
(PPQ) - induced writhing test was perf ormed . The ability of morphine to in­
hib i t  the PPQ- induced writhing respons e was evaluated in STZ- induced d ia­
b etic , and fasted + insulin pretreated mice vs control . In Table  14 , i t  
can b e  seen that the STZ- induc ed d iabetic mice wer e s ignif icantly les s  
s ens itive t o  the ef f ec t s  o f  morphine in this assay . The hypoglycemic mice 
were somewhat ,  but no t s ignif icantly mor e  s ens itive to the effects  o f  mor­
phine than were control mice . Neither of the exper imental pretreatments  
had any signif icant effect  on  the writhing respons e elicited by PPQ alone . 
None of  the log-dose response curves deviated s ignif icantly from 
parallelism .  
The next series of  experiments were designed t o  fur ther eluc i­
date the mechanism ( s )  respons ible f or dif f er ences in the antinocicep t ive 
p o tency of morphine seen in STZ-induced diabetic mice .  
c .  Duration of Ac tion of Morphine 
If , as a resul t of STZ- induc ed diabetes , the absorp tion , b io­
trans formation or excretion of  morphine were al tered , this could ac count 
f or the drug ' s  decreas ed potency in the diabetic mic e .  A change in one 
of these three parameters might be indicated if the duration of antinoc i­
cep tion following a single dose of  morphine d if f ered for STZ-diabetic mice 
vs  control mice , unless two or more parameters wer e al tered in opp o s i t e  
d ir ec tions and in equal amounts . A graph showing the % MPE at several 
t imes af ter morphine adminis tration in contro l  and STZ-induced diabetic  
mice  is presented in Figur e 4 .  In bo th groups o f  mice , peak ant ino c icep-
Table 14 
The EDSO of  Morphine in Control , Strep to zotocin ( STZ ) ­
Induced Diabetic and Fas ted + Insulin Pretreated Mice 
in the Phenylquinone-Induced Wri thing Tes t 
9 S %  Conf idence 
Pretreatment (n/dose)  EDSO 
a Limit s  o f  EDSO Potency Ratio  
Control ( 6 )  
STZd ( 6 )  
Fas ting + Insulind 
a mg morphine /kg 
b vs c ontrol 
0 . 7 4 
2 . 16 
( 6 )  O . SO 
c 200  mg/ kg STZ i . v .  6 days earlier 
0 . 3 9 - 1 . 3 9 
1 . 17 - 3 . 9 9 
0 . 30 - 0 . 8 2 
d 18 hr fast + 1 U/kg insulin s . c .  20 min before morphine 
e p < O . OS vs control (Lit chf ield and Wilcoxon , 194 9 )  
1 . 00 
0 . 34e 
1 . 48 
S 7  
b 
58 
Figure 4 
Duration o f  ac tion of  morphine ( 4  mg/ kg s . c . ) in control and S trep t o z o t o c in 
( STZ ) -induced diabetic mice as quant itated in the tail-fl ick tes t . S ix 
dif f er ent mic e were used at each time po int . STZ-induced diabetic mice 
wer e inj ected with 200 mg/ kg STZ i . v .  6 days earlier . 
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t ion was seen at 20 min ( the time routinely used in tail-flick experiments ) . 
In this laboratory , 25% MPE is cons idered to be  pharmacologically s ignif i­
cant : In both groups of mice the % MPE reached 2 5 %  at 10 min , and dropped 
to that mark at 8 0  min. Thus , there appears to be no diff erence in the 
duration of ac tion, although the respons e in the STZ-induced diabetic mice 
was lower than contro l  mice at all time points . 
D .  Naloxone Antagonism of  Morphine-Induc ed Antinoc iception 
The ability o f  naloxone , a pure narco tic antagonis t ,  to  inhib it  
the ef f ec ts of morphine in  the tail-flick tes t was determined in  c ontr o l  
and S TZ- induc ed diabetic mice ( Table 15 ) . A signif icant differ enc e i n  the 
pA2 or slope of the log dose-respons e curves (% MPE vs log-do s e  naloxone) 
us ing a cons tant do se of  morphine would sugges t that morphine and naloxone 
are no t interac ting at the same recep tor in STZ-induced diabetic and con­
trol mice . Us ing a modif ication of the method of Takemor i  et  al e ( 19 6 9 ) , 
no signif icant dif f erence in the pA2 values were observed . The s lopes of  
the log dose-response curves also did no t dif f er s ignif icantly from 
parallelism (Litchf ield and Wilcoxon , 1949 ; Barr et  al . ,  1 9 7 6 ) . There was , 
however , a decreased potency of  morphine in STZ-induced diabetic mic e  
compared with control mice  a t  all do s es of  naloxone . 
E .  Rad iotracer Studies 
One possible reason for the diff erent s ens itivities to morphine 
s hown by several pretreatment group s is that the level of  morphine in the 
brains of  these animals could be  altered as a result of the pretr eatment . 
In a s eries of  three experiments , summarized in Tab le 16 , i t  was f ound 
that levels o f  3H-morphine equivalents in the brains of control , STZ­
induc ed diabetic and insulin- tr eated STZ-induc ed diabetic mice was almo s t  
identical , al though the antinoc icep tive potency o f  the morphine was s ig-
d pA2 
Table 15 
Naloxonea Antagonism of  Mo rphineb-Induced Antinocicep tion in 
Streptozotocin (STZ ) - Induced Diabe tic and Control 
Mic e  in the Tail-Flick Tes t 
Control STZc 
1 . 23 1 . 4 6 
6 0  
9 5 %  Confidenc e Limit s  of  pA2 0 . 82 - 1 . 64 0 . 74 - 2 . 18 
e S lope 
Potency Ratiof 
9 5 % Conf idence Limits of  
Potency Ratio 
3 . 25 
1 . 00 
a 0 . 03 ,  0 . 1  or 0 . 3  mg /kg s . c . , n = 6 /dose  of naloxone 
b 6 mg/ kg s . c .  
c 200 mg/kg STZ i . v .  6 days earlier 
d Takemori  et al . ( 19 6 9 )  
e Litchf ield and Wilcoxon ( 1 94 9 )  
f vs contro l ( Barr et  al . ,  19 7 6 )  
g p < 0 . 05 v s  control ( Barr e t  al . ,  197 6 )  
7 . 96 
3 . 9 2 g 
1 . 44 -10 . 67 
Pretrea tment 
Control 
STZe 
Table 1 6  
Levels of 3H-Morphine Equivalents and Antinoc ic ep t ion i n  Control , Strep tozotocin 
( STZ ) -Induced Diabetic , and Insul in-Pretreated STZ- Induced 
Diabetic Mic e Adminis ter ed 3H-Morphin& 
% MPEb (n)  3 b c Brain H '  (n)  3 b d Serum H '  
5 5 . 6 ± 5 . 7 ( 4 1 )  1 2 6 . 1  ± 5 . 0  ( 3 3 )  2 7 11 . 5 ± 14 7 . 1  
3 0 . 2 ± 5 . 3
g ( 20 )  119 . 1  ± 8 . 1  ( 1 9 )  2909 . 8  ± 2 3 7 . 1  
(n) 
( 29 )  
( 20 )  
STZ + Insulin f 69 . 2 ± 7 . l
g , h  ( 20 )  119 . 1  ± 8 . 9  ( 20 )  3888 . 6  ± 2 9 2 . 0g ( 20 ) 
a Morphine sulfate 4 mg/kg 2 0  min earlier · 
b -
X ± S . E . 
c ngEq of morphine / g  brain tissue 
d ngEq of  morphine/ml serum 
e 200 mg/kg STZ i . v .  6 days earlier 
f 200 mg/kg STZ i . v .  6 days earlier + 3 U/kg insulin s . c .  20 min before morphine 
g 
p < 0 . 05 vs control using S tudent ' s  t-test  
h p < 0 . 05 vs STZ using Student ' s  t-test 
0\ 
f-' 
6 2  
nif icantly les s . No s ignif icant dif f erence was found in the s erum-3H-
morphine equivalent levels of contr ol and STZ-induced diabetic mic e . The 
S TZ- induc ed diabetic mice also adminis t ered insulin , however , had a s ig­
nif icantly higher serum-3H level than either of  the o ther two group s . 
The r eason for this is unknown . It can be  concluded from thes e data that 
the decreased respons e of  S TZ- induc ed diabetic mice to morphine is pro­
bably no t due to a change in the distribution of  morphine in the brain or 
blood . 
I I I .  Other Pharmacologic S tudies 
The next series of experiments were des igned to determine whe ther 
the decreas ed potency of morphine in STZ-induced diabe tic mice would occur 
f or lethality as well as antinocicep tion . Also  under inves tigat ion was 
whether altered sens itivity to non-narcotic centrally acting drugs  would 
occur . 
A .  LDSO Determinations 
1 .  Morphine . STZ- induced diabetes caused a s ignificant increase  
i n  the acute lethality of  morphine sulfate (Table 17 ) . The s lopes o f  the 
do s e- response curves did not d if f er s ignif icantly from parallelism ( 1 . 7  v s  
1 . 5 ) .  The LD50 and 95%  c onf idence limits i n  control  mic e were 5 0 3  mg/ kg 
and 4 0 9- 618 mg/kg , respec tively . This  is s imilar to the LDSO of morphine 
r epor ted in the literatur e ,  531 mg /kg (Eddy , 1948 ) . In STZ-induced d ia­
betic mice , the LDSO and 95%  conf idence limits were 3 3 7  mg/kg and 2 4 7 -
4 5 9  mg/ kg , respec tively . This results  in a potency ratio (LD5 0  contr o l /  
LDSO STZ)  of  1 . 5 ,  which is s ignif icant at p < 0 . 05 .  All animals showed 
increased activity and S traub tail within 5 min f ollowing the morphine 
adminis tration. Deaths occurred following convuls ions in contro l  mic e  
Table 17  
The Acute LD50 of  Subcutaneous ly Adminis t er ed Morphine Sulfate 
in Control and S trep t o zotocin ( S TZ ) - Induced Diab etic Mic e  
Pretr eatment Dose ( s . c . )  n Number Dead ( % )  
Control  30 0  mg/kg 8 1 ( 1 1 )  
5 0 0  9 4 ( 4 4 ) 
600 9 5 ( 5 6 )  
7 0 0  9 8 ( 8 9 )  
LD50  
c = 503 mg/kg ; 95%  Conf idence Limit s  409-618 mg/kg ; Slope = 1 .  5 ; 
95%  Conf idenc e Range = 1 . 1-1 . 9 
STZa 300  9 4 ( 4 4 )  
500  1 6  1 1  ( 6 9 )  
600  9 9 ( 10 0 )  
7 0 0  9 9 ( 10 0 )  
LD 50 = 3 3 7  mg /kg ;  9 5 % Conf idence Limit s  = 247-4 5 9  mg /kg ; Slope = 1 . 7 ;  
95%  Conf idence Limits = 0 . 9-3 . 4  
a 200 mg /kg STZ i . v .  8 days  earlier 
b 24 hr f ollowing morphine inj ection 
c Litchf ield and Wilcoxon ( 19 4 9 )  
d p < 0 . 05 v s  contr o l  
6 3  
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generally 60-120 min af ter morphine adminis tra tion . Diabetic mic e  app ear­
ed to die of respiratory d epress ion , wi thout convuls ions , although exci ta­
t ion was observed initially . No s igns of  gross  pathology wer e observed . 
So , S TZ-diabetic mice are less sens itive to morphine ' s  antinocicep t ive  
e f f ec ts but more sens itive to its lethali ty . 
2 .  Methadone . Adminis tration o f  toxic do ses of  methadone t o  
S TZ-d iabetic and control mice caus ed Straub tail initially , b u t  was 
f ollowed by behavioral and respiratory depres s ion , and death 30-90  min 
f ollowing adminis tration in b o th groups of animals . No signs of gro s s  
pathology were obs erved . The acute s . c .  LDSO of  methadone was no t s i gnif­
icantly dif f erent in STZ- induc ed d iabetic mice vs control ( Table 1 8 ) . The 
s lopes of both dose-respons e curves ( c ontrol  vs STZ)  were nearly id entical 
( 1 . S6 vs 1 . 49 ) as were the LDSO ' s ( 3 6 . 7  vs 3 S . l ) . The report ed acute  s . c .  
LDSO o f  methadone is 33  mg/ kg ( Chen , 1948 ) . When cons idered with the tail 
f lick data for methadone and morphine this sugges ts  that although morphine 
and methadone are clas s if ied pharmacologically as narco tic analgesics , 
their mechanisms and / or s ites of action in the CNS may be dif f er ent . 
3 .  Nicotine . STZ- induced diabetes d id not have a s ignif icant 
e f f ec t  on the acute , oral LDSO of nicotine , a central cholinergic s t imu­
lant (Table 19) . Convulsions occurr ed 5-15 sec f ollowing intubation , 
f ollowed immediately by death . No s igns of  gros s  pathology wer e  obs erved . 
The LDSO of nicotine in control mice was 6 S . 5  mg/kg with 9 5 %  conf idenc e 
l imit s  of 31 . 6 to 135 . 9  mg/kg . In STZ- induc ed d iabetic mic e , the LDSO 
was 7 7 . 3 mg /kg with 9 S % c onf idence limits of 34 . 4  to 174 . 1  mg / kg . The 
s lopes of the dose-response curves wer e  no t s ignif icantly diff erent . Oral 
LD5 0  values for nicotine alkalo id repor t ed in the literature vary gr eatly 
( Lars en et al . ,  1961)  although 24  mg/kg is generally accep ted as the 
Table 18 
The Acute LD5 0  of  Subcutaneously Adminis tered Methadone 
Hydro chloride in Control and Streptozotocin ( S TZ ) -Induced Diabetic Mice 
Pretreatment Dose ( s . c . ) n Number Dead ( % ) b 
Control 18 10 0 ( 0 )  
24 10  1 ( 1 0 )  
3 0  10 5 ( 50 )  
5 6  10 9 ( 8 0 )  
100 10 10 ( 10 0 )  
LD50
c 
=
 3 6 . 7 mg/kg ;  9 5 %  Conf idence Limits = 2 9 . 3-46 . 0  mg/kg ; Slope = 
9 5 %  Conf idence Limits  = 1 . 1-2 . 1  
STZa 24 10 1 ( 10 )  
3 0  9 4 ( 4 4 )  
5 6  1 0  9 ( 9 0 )  
LD50 = 35 . 1  mg/kg ; Conf idence Limits = 2 5 . 3-48 . 7  mg/ kg ; Slope = 1 . 4 ;  
95%  Conf idence Limits = 1 . 0- 2 . 1  
a 200 mg /kg STZ i . v .  8 days earlier 
b 24 hr fo llowing methadone inj ection 
c Litchf ield and Wilcoxon ( 1 9 4 9 )  
1 .  6 ;  
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Table 19  
The Acute Oral LD50 of  Nicotine in Control and S tr ep tozotocin 
( STZ ) - Induced Diabetic Mice 
Pretreatment Dose n Number Dead ( % ) b 
Control 7 . 6  mg/ kg 8 0 ( 0 )  
13 . 5  8 0 ( 0 )  
24 . 0  8 0 ( 0 )  
4 2 . 7  8 3 ( 3 7 . 5 ) 
7 6 . 0  8 4 ( 50 . 0 ) 
202 . 0 8 7 ( 8 7 . 5 ) 
240 . 0  10 10 ( 1 0 0 )  
6 6  
LD50c = 65 . 5  mg/kg ;  9 5 %  Conf idence Limits = 3 1 . 6-135 . 9  mg/kg ; S l o p e  = 2 . 8 ; 
95%  Conf idence Limits  = 0 . 8-10 . 6  
13 . 5  
24 . 0  
4 2 . 6 7  
7 6 . 00 
2 02 . 0  
6 
8 
8 
7 
8 
o ( 0 )  
2 ( 2 5 )  
3 ( 3 7 . 5 ) 
3 ( 4 2 . 9 ) 
6 ( 7 5 . 0 ) 
LD so = 7 7 . 3  mg/kg ; 95%  Conf idence Limits  = 34 . 4-17 4 . 1  mg /kg ; Slope = 1 . 4 ; 
95%  C onf idence Limit s  = 0 . 8-32 . 5  
a 200  mg /kg STZ i . v .  10 days  earlier 
b 24  hr af t er nicotine adminis tration 
c Litchfield and Wilcoxon ( 1 94 9 )  
minimum lethal dose . In Table 18 it  can be seen that 24  mg/ kg was no t 
l etha l ,  but at 42 . 7  mg/ kg , 37 . 5% lethality occurred . 
B .  Duration of Hexobarbital- Induced Anes thes ia 
Pretreatment of f emale Swiss  mice with either STZ or dextr o s e  
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d id no t have a signif icant ef fect upon the duration of  hexobarbital-induc ed 
anesthesia . The mean duration of anes thes ia ranged from 44 . 1  min ( ST Z )  
t o  51 .  0 min (dextrose)  with control  mice having a duration of  anes thes ia 
of 4 9 . 1 min (Table 20 ) . 
Fo llowing inj ections of  phenobarbital sodium for f ive d ays , the 
durat ion of  hexobarbital- induced ane s thes ia in STZ and control mice d e­
cr eas ed to 13 . 7  and 13 . 5  min , respec t ively (Table 21 ) . These durations 
were s ignif icantly shorter than each group ' s  pre-phenobarbital durations 
of anes thesia ( 13 . 7  vs 4 9 . 1  min in control mice ; 13 . 5  vs 44 . 1  min in STZ­
induc ed d iabetic mice ) , but the two pos t-phenobarbi tal durations were not 
s igni f icantly dif f er ent f rom each o ther . Thes e  data are in agreement with 
tho s e  of Lamson et al . ( 1 9 5 1 ) . 
It thus appears that the hyperglycemic aspect of experimental 
d iabetes selec t ively alter s the antinocicep t ive potency of cer tain nar­
c otic analges ics . 
IV . Analyses of Biochemical Changes Induced by Pretreatments 
A.  S erum Glucose  Levels ( SGL) 
1 .  Swiss  mice . S ince light etherization was required t o  enable 
rap id blood sampling , the effec t  of  ether inhalat ion on SGL was determined . 
Blood was collected initially by cut t ing o f f  approximately 5 rom of  the 
mous e ' s tail . Thereaf ter , each mouse was etheri z ed and blood collected 
from the retroorbital s inus . Because  s er ial blood samples were occass ion-
Table 20  
Duration of Anes thes ia in Control , S treptozo tocin ( STZ ) -Diabetic 
and Dextrose-Pretreated Mice following Inj ect ion 
of Hexobarbital ( 100 mg /kg i . v . ) 
Pretreatment n Duration (min) a 
Control 9 49 . 1  ± 4 . 1 
STZb 7 44 . 1  ± 5 . 0  
Dextro s e  c 5 51 . 0  ± 8 . 8  
a 
X ± S . E .  
b 200 mg/kg STZ i . v .  6 days earlier 
c 0 . 0 28 mo l/kg i . p .  25 min before hexobarbital 
68 
Tab le 21 . 
Ef f ec t  of Inj ections of  Phenobarbital Sodium for 5 Days in Contro l  
and Streptozotocin ( STZ ) -Diabetic Mice o n  the Duration o f  
Hexobarbital-Induced Anes thesia ( 100  mg/kg i . v . ) 
Pret,r eatment n 
Control 9 
6 
a X + S . E .  
b • 200 mg/kg STZ i . v .  13 days earlier 
Durat ion (min) a 
13 . 7 + 0 . 7 c 
13 . 5  + 1 . 0c 
c p < 0 . 001 vs non- induc ed durat ion in Table 20  for same pretr eatment , 
us ing Student ' s  t-tes t 
6 9 
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ally required , the eff ec ts o f  frequent etherization were also inves tiga ted . 
These data appear in Table 22 . At time 0 ,  blood samples from the s inus 
had a s ignificantly higher SGL than samples of  blood from the tail . At 
4 5 ,  90 and 180 min later , s inus blood samples did no t have s ignificantly 
d if f er ent SGL than time 0 tail or s inus samples . The s ignif icantly higher 
SGL of s inus blood at time 0 could be due to a s tress-induced release  o f  
ep inephrine which would temporarily increase SGL a s  a result of  the tai1-
cut t ing at f ir s t  and be detec ted in the s inus blood sample taken immed­
iately af terwards (Himms-Hagen ,  1 9 67 ) . The SGL from the time 0 s inus 
punc ture was much closer to the time 0 tail values ( 181 vs 142  mg/ d 1 )  than 
to the level requir ed for an animal to be cons ider ed hyperglycemic under 
the criteria es tablished (> 250 mg/d1 ) , and in sub sequent exper iments , 
wher e tail-cutting was no t initially performed , control SGL wer e never 
s ignif icantly dif f erent from the af orement ioned time 0 tail-value of the 
f ir s t  exper iment ( Table 2 2 ) . On the basis of  these data , it  was c on­
c luded that light etheri zation did no t s ignif icantly aff ec t the animals '  
SGL suf f iciently to cause a p o s s ible mis interpretation of  the data . 
For both dextrose and insulin pretreatments , the alteration 
in SGL (hyp er- and hypoglycemia , resp ec tively ) were obs erved by 3 0  min 
f o llowing inj ec tion and p er sis ted through 60 min ( Tab le 23 ) . The ef f ec t  
p eaked for bo th pretr eatments a t  45  min , s o  4 0-45 min was chos en a s  the 
pretr eatment time . 
The effects of the various pretr eatments on SGL of  mice ar e 
shown in Table 24 . Blood samp les were taken at the t ime corresponding t o  
the point where the effect of morphine would have been determined . S ig­
nif icant incr eases above control levels were seen in STZ-induc ed d iab e t i c  
and d extrose pretreated mice , whereas fas t ing or fas ting + insulin caus ed 
Table 2 2  
Ef f ec t of  Sampling Me thod o n  Serum Glucose 
Levels ( SGL) in Control  Mice  
Time SGLb 
o ( tail) 
a blood collec ted from retroorbita1 sinus 
b -mg/dl , X ± S . E . , n = 5 
c p < 0 . 05 vs " 0" time ( tail )  using S tudent ' s  t-test 
142 . 0  ± 11 . 0  
181 . 0  ± 9 . 0c 
151 . 8  ± 1 3 . 1  
164 . 8  = 7 . 0  
153 . 0  ± 10 . 9  
7 1 
Table 23 
Duration of Ef f ec t s  of  Dextrose- or Fas ting + Insulin­
Pr etr eatment on Serum Glucose Levels in Mice  
Pretreatment 
7 2  
T . b l.me Control Dextro s e  c Fas ting + Insul ind 
a 129 . 7 ± 6 . 8  
30 12 7 . 8  ± 5 . 2 
4 5  1 29 . 2  ± 6 . 7  
6 0  12 6 . 8  ± 5 . 1  
90  12 9 . 3  ± 6 . 0  
120 12 6 . 8 ± 5 . 4  
a -mg/ dl , X ± S . E . , n = 6 
Serum Gluco s e  Levelsa 
118 . 3 ± 3 . 9  
3 07 . 7  ± 2 6 . le , f  
3 2 7 . 0  ± 2 9 . 2e , f  
3 02 . 5  ± 24 . 0e , f  
2 39 . 8  ± 9 . 4 e , f  
184 . 3  ± 10 . 7 e , f  
b minutes af ter inj ection of dextrose or insulin 
c 0 . 0 2 8  mo l/kg i . p .  
d 18  hr fas t + 1 U/kg insulin s . c .  
e p < 0 . 05 vs time " 0 " using Student ' s  t- test  
f p < 0 . 05 vs control at same t ime us ing S tud ent ' s t-tes t 
9 1 . 5  ± 2 . 7 f 
6 7 . 3  ± 2 . 4e , f  
3 7 . 3  ± 2 . 4e , f  
40 . 5  ± 2 . le , f  
48 . 2  ± 2 . 0e , f  
5 2 . 0  ± 2 . 3 e , f  
Table 24 
Serum Glucose  Levels ( S GL)  in Swiss  Mice 
Receiving Various Pretreatments 
Pretreatment 
Control  
a Morphine Sulfate 
STZb 
STZ + Insu1inc 
d Dextro s e  
d Fruc tos e 
d 3-0-methy1 glucose 
F . e ast1.ng 
Fas t ing + Insu1inf 
a 8 mg /kg s . c .  20 min before samp ling 
n 
6 
8 
8 
2 2  
6 
6 
6 
6 
6 
b 2 0 0  mg/kg Streptozotocin ( STZ)  i . v .  6 days earlier 
1 29 . 7  ± 6 . 8  
7 3  
138 . 6  ± 5 . 8  
4 7 2 . 6  ± 3 4 . 2h 
7 5 . 4  ± 5 . 4h 
3 27 . 0  ± 2 9 . 2h 
120 . 2  ± 4 . 7  
11 6 . 2  ± 4 . 2  
9 5 . 5  ± 2 . 4h 
48 . 2  ± 2 . 0h 
c 200  mg/kg STZ i . v .  6 days earlier + 3 U/kg insulin s . c .  40  min before 
sampling 
d 0 . 0 2 8  mol/kg i . p .  45 min before sampling 
e 18 hr fas t  before sampling 
f 18 hr fas t + 1 U/kg insulin s . c .  40 min before sampling 
g mg/ d1 , X ± S . E .  
h p < 0 . 05 vs control using S tudent ' s t-test  
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s ignif icant decreases from control  levels . STZ-d iabetic animals  adminis­
t ered insulin also  had s ignif icantly lower SGL than control . The varia­
b ility in the severity of the animals ' diabetes makes it  impo s s ible  to 
predict  what do se of insulin is suf f icient to r evers e  the hyperglycemia 
without causing mild hypoglycemia in some mice . It should be no ted that 
the d if f erence in the SGL of STZ-induced d iabetic and dextro s e-pretreated 
mice  vs control is f our times the d if f erence between fas ting and insulin 
vs contr o l .  Mice that have d ied from convuls ions following inj ec tions of  
higher doses of insulin have had SGL < 30  mg/dl (data not shown) . Pr e­
treatment of mice with fruc tose or 3-0-me thyl glucose , unlike dextr o s e  
pretrea tment , had n o  signif icant ef fec t  o n  SGL, y e t  both dextr o s e  and 
fruc tose pr etreatments caus ed s ignif icant decreases in morphine potency . 
Morphine sulfate ( 8  mg/kg s . c . ) had no s ignif icant effects on SGL . 
2 .  Rat s .  The ef f ec t  o f  STZ-induced diabetes on SGL in rats  i s  
shown in Table 25 . The s ignif icant increase in SGL induced by S TZ-diab etes 
is s imilar for bo th Swiss mic e  and rats . 
3 .  C57Bl /KsJ  mic e .  The mutation "diabetes " in thes e  mic e  
f ollow classical Mendelian genetics (Hummel e t  al . ,  1 9 6 6 ) . Thus only 
tho s e  mice homozygous for the gene "dbm" should be diabetic and hypergly­
cemic . The heterozygote (dbm/++) was cons idered a better control geno­
type than the pur e wild type (++/++) . The d iabetic mice had s igni f icantly 
higher SGL than the heter o zY$o t ic controls ( Table 2 6 ) . 
B .  Brain Glucose  Levels in Swiss  Mic e  
The ef f ec ts o f  various pretreatments o n  levels of  gluc o s e  in 
mous e  brains is shown in Table 27 . The level of glucose  in the brains o f  
the c ontrol mice were s imilar t o  that r epor ted by King et  al . ( 1 9 7 7 )  for 
male mice . With the excep tion of STZ-induc ed d iabe tic mice adminis tered 
Table 25 
S erum Glucose Levels ( SGL) in Streptozotocin ( S TZ ) - Induced 
Diabetic Rats Compared with Vehic le-Inj ected Control Rat s  
Pretr eatment n 
Control 6 
6 
a 60 mg/ kg STZ i . v .  6 days earlier 
b -mg / dl , X ± S . E . 
c P < 0 . 05 vs control using S tudent ' s t-tes t  
104 . 2  + 4 . 7  
3 90 . 0  + 3 5 . 8c 
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Table 2 6  
Serum Glucose Levels ( SGL) in Spontaneously Diabetic Mice  
Compared with Their Nond iabetic Littermates 
Geno type 
dbm/++ (nondiabetic ) 
dbm/dbm (diabetic ) 
a / -mg d1 , X ± S . E . 
n 
8 
8 
b p < 0 . 05 vs dbm/++ using S tud ent ' s  t-tes t 
153 . 4  ± 5 . 5  
3 54 . 8  ± 2 1 0 8b 
7 6  
Table 2 7 
Br ain Glucose Levels in Swiss Mice Receiving Var ious Pr etreatment s  
Pretreatment Brain Glucose  Leve1f 
Control 2 . 20 ± 0 . 11 
STZ� 5 . 17 ± 0 . 20g 
STZ + Insulin b 3 . 13 ± 0 . 3 2 g , h  
Dextro s e  c 5 . 3 1 ± 0 . 42g 
Fas t ing d 1 .  7 6  ± 0 . 13 g 
Fas ting + Insulin e 0 . 4 1 ± 0 . 04 g 
a 200 mg/kg Streptozotocin ( STZ ) i . v .  6 days earlier 
b 200  mg /kg STZ i . v .  6 days earlier + 3 U/kg insulin s . c .  40  min before 
sacrifice 
c 0 . 028  mo l/kg i . p .  45  min before sacr if ice 
d 18 hr fas t  before sacr if ice 
e 18 hr fast + 1 U/kg insulin s . c . 4 0  min before sacr ifice 
f mMo 1es /kg wet weight , X ± S . E . , n = 6 
g p < 0 . 05 vs control us ing S tudent ' s  t-tes t 
h p < 0 . 05 vs STZ us ing S tudent ' s  t-test 
7 7  
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insul in , changes in SGL ( Table 24 ) wer e s imilar to changes in brain gluco s e  
levels . That i s  t o  say , pretreatments that caused increas ed SGL produced 
c orrespond ingly increased brain glucose levels , and pretr eatment that 
caused decr eased SGL also caused decreased brain glucose  levels . Howev er , 
while inj ec tion of 3 U insulin/kg t o  STZ-diabetic mice completely r evers ed 
their hyperglycemia and , in fac t ,  caused some hypoglycemia , this dos e  o f  
insul in was not suf f icient t o  return brain glucose  levels t o  normal . 
These levels were s till signif icantly greater than control level s , but 
also signif icantly lower than tho s e  of  STZ-diabetic mice without insulin 
inj ec tion . 
C .  Serum Insulin Levels in Swiss  Mice 
The effects of various pretr eatments on s erum insulin levels ar e 
shown in Table 28 . When sugars or insulin wer e  administered , serum insu­
lin levels were determined at the time when morphine ' s effects would have 
been determined . Morphine sulfate (6  mg/kg s . c . ) did not alter s erum 
insulin-levels 20 minutes af t er inj ection . I t  can be  s een that f a s t ing 
alone did not have a signif icant ef f ec t  on serum insul in levels . Sub­
cutaneously adminis tered porcine insulin in fasted and STZ-diabetic  mic e  
( 1  and 3 U/kg , respec tively) s ignif icantly increased serum insulin levels 
from a mean of  8 . 86 uU/ml in control mic e  to 38 . 00 and 7 7 . 83 uU/ml re­
spect ively . Thus , bo th s erum insulin levels and SGL (Table 24 ) in insulin­
inj ec ted STZ-diabetic mice were s ignif icantly higher than in insulin-inj ect­
ed fasted animals . 
Inj ec tion of dextrose , fruc tose or 3-0-methyl gluco s e  s ignif i­
cantly increased serum insulin levels vs control 45  min af t er inj e c tion . 
Dextr ose had the greates t ef fect on s erum insulin levels , while fruc t o s e  
and 3-0-methyl glucose had an equal ef f ec t .  
7 9  
Table 28 
S erum Insulin Levels in Swiss Mice Receiving Various Pretr eatments  
Pretr eatment n Serum Insulin Levela 
Control 
Morphine Sulfate 
b 
STZc 
STZ + Insulin d 
Dextro s e-45 e 
Fructose-45 e 
3-0MG-45 e 
Fas t ing f 
Fas t ing + Insuling 
a / -uU ml , X ± S . E . 
b 6 mg/ kg s . c .  20 min before sampling 
7 
7 
6 
6 
7 
7 
5 
7 
6 
c 200  mg/kg Streptozotocin ( STZ)  i . v .  6 days before sampling 
8 . 8 6 ± 3 . 30 
7 . 57 ± 1 . 34 
0 . 67 ± 0 . 33h 
7 7  . 83 ± 9 . 4 lh 
42 . 4 3  ± 5 . 4 7h 
2 2 . 5 7 ± 5 . 4 2h 
2 7 . 40 ± 6 . 48h 
6 . 8 6 ± 1 . 37 
3 8 . 00 ± 4 . 47h 
d 200  mg/kg STZ i . v .  6 days  earlier + 3 U/kg s . c .  60  min before s amp l ing 
e 0 . 0 2 8  mol/kg i . p .  45 min before sampling 
f 18 hr fas t  before sampling 
g 18 hr fast + 1 U/kg insulin s . c .  40 min before sampling 
h p < 0 . 05 vs control  us ing S tudent ' s  t-test 
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The only pretreatment group who se serum insulin level was s ig­
nif icantly lower than control was the STZ-induc ed d iabetic mic e . I t 
should be no ted that the STZ-diabetic group had s erum insulin levels s ig­
nif icantly lower (about 1 / 10 )  than the control group , while the d ex tr o s e­
pretr eatment group had s ignif icantly higher ( almos t  lOX) serum insulin 
l evels than the control group . There is a hundred fold dif f erence in 
s erum insulin levels between the STZ- and dextrose-pretr eatment group s , 
while s erum glucose levels ( Table 2 2 )  and morphine potency ( Table 4 )  in 
these two group s are similar . These results  indicate that the altered 
potency of  morphine is not due to a change in s erum insulin levels .  
D .  Brain Water Content and Serum Osmo lar ity in Swiss Mice 
STZ- induced d iabe tes had no s ignif icant effect  upon brain water 
content or serum osmolarity , suggesting that if the d iabetic hyperglycemia 
d id tend to cause central dehydration due to an increase in s erum o smolar­
ity ,  o ther per turbations compensated for this change ( Table 29 ) . 
Table 2 9  
Brain-Water Content and Serum Osmolar i ty in 
Streptozo tocin ( STZ) - Induc ed Diabetic and Control Mic e 
Pretreatment 
Contro l  
a X ± S .  E .  
a b Brain-Water Content ' 
7 3 . 0  ± 0 . 5  
7 1 . 9  ± 0 . 3  
b W .. -=e-=t�w:...:e:..:i::s;gl.:.h:..:t=-----=d:..:r:.l.y---...:w.:..:e:..:i=.;g;z.:h::...=.t - - - - x 100 = % water ; n = 10 Wet weight 
c m Osmo lar Units /kg ; n = 6 
d 200  mg/kg STZ i . v .  6 days earlier 
Serum Osmolar itya , c  
3 23 ± 1 
3 3 2  ± 6 
8 1  
DISCU S S ION 
The data presented in this disser tation indicate tha t STZ-induced 
diabetes can af fect  the potency of  some centrally-acting drugs (mo s t  
no tab ly morphine) while no t af f ec t ing the po tency of  o ther drugs , even 
some that are considered to be in the same pharmacologic class ( e . g .  
methadone ) . 
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The results o f  a number o f  experimen ts suggest the hyp o thesis that 
it  is the hyperglyc emic aspec t of the d iabetic s tate which is initially 
respons ible for the observed decrease in the antinociceptive po tency o f  
morphine . STZ- induced diabetic mice and rats , and spontaneously d iabetic  
mic e were all s ignif icantly less s ens itive to the antinociceptive e f f e c t s  
of  morphine than their respec tive nondiabetic controls . When insul in was 
administered to STZ- induced mic e  to lower their BGL ' s ,  their sens i t ivity 
to the antinocicep t ive effects  o f  morphine returned to control values . 
In contras t to the hypoinsulinemia which occurs with hyper glyc emia 
in STZ-induced diabetes , pretreatment of mic e with dextrose caused hyp er­
glycemia and hyperinsulinemia ,  yet the s ens itivity of  these two groups of  
mice t o  the antinociceptive effects  of  morphine wer e  both s ignificantly 
lower than mice with normal BGLs . When insulin was adminis t ered to  dex­
tro s e-pretreated mic e to prevent the dextrose-induced hyperglycemia f r om 
occurr ing , sensitivity to the antinocicep t ive eff ec ts o f  morphine was no t 
s ignificantly dif f erent than in control mice . 
The fas ted plus insulin (hypoglycemic ) pretr eated mice were mor e ,  but 
no t s ignif icantly more sens itive to the antinocic ep tive effects  of  levor­
phanol in the tail-flick tes t  and the effects of  morphine in the 
phenylquinone-induced wri thing tes t . Thes e  were the only two ins tance s  
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where a pretr eatment did no t fo llow the pattern generally seen in the s e  
experiments . This could be explained by the fact that the differ ence in 
BGL ' s between the fas ted plus insulin pretreatment group and control mic e  
was not a s  great a s  the dif f erence between the pr etreatment-induced hyper­
glycemic mice and controls . Making their hypo glycemia any more s evere 
caused convuls ions and death , however (data no t presented ) . 
Spontaneously-diabetic mic e are hyperglycemic and hyper insulinemic 
( Coleman and Hummel ,  196 7 ) , and have a decreased s ens itivity to morphine ' s 
antinoc iceptive eff ects . This suppor ts the hyp o thesis that hyper glycemia 
is the condition respons ible for the decreas ed sens itivity to the anti­
nocicep tive effects of  morphine seen wi th diabetes-like syndromes .  
Insulin adminis trat ion to STZ-induced diabetic mic e ,  which res tored 
BGL ' s  and the sens itivity to morphine ' s  antinocicep t ive effects to control  
value s , decr eas ed brain glucose levels signif icantly lower than before 
insulin , but s t ill signif icantly greater than control levels . This sug­
ges ts that brain glucose levels are no t as impor tant as BGL ' s ,  in alter ing 
the s ens itivity of  animals to morphine . I t  has previously been repor ted 
that BGL ' s may no t always accurately reflec t brain glucose levels ( Thur s t on ,  
197 6 ) . 
An attemp t was made to correlate the BGL ' s  o f  individual mice wi th 
their sensitivity to morphine ' s  ant inocicep t ive effects . A s tatis t ically 
significant correlation was no t found , sugges ting that a threshold mus t  b e  
achieved for a signif icant change in s ens itivity t o  morphine t o  occur . 
S everal experiments  were performed in an attemp t to elucidate the 
mechanism whereby increasing BGL cause a decreas e in the antinociceptive 
potency of morphine . Pretreatment of  mice with fructo s e , like dextr o s e , 
caused a significant decr ease in morphine ' s  antinociceptive potency , while 
pr etreatment with 3-0-methylgluco s e  had no effec t . This sugges ts tha t  
changes in morphine ' s  potency can be af f ec ted only b y  cer tain sugar s . 
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The results of  the expertment which demons trated that there was no 
dif f er enc e in the duration of  action of morphine in STZ-induced d iabetic 
and c ontrol mice sugges ts that the ab sorp tion , metabolism and excretion o f  
morphine are not aff ec ted b y  STZ-induced diabetes . However , this can no t 
be  ruled out solely on the basis of  there being no dif f erence in the dur­
ation of  ac tion . For example , two or more  o f  thes e  parameters could b e  
alter ed in opposite dir ec t ions yield ing n o  ne t effect o n  the duration o f  
action of  morphine . 
Patrick et al . ( 1 9 7 5 )  have r eported that the level of morphine in the 
brains of mice can be correlated with both the dose of  morphine adminis­
t ered and the degree of ant inoc icep tion obs erved . Control , S TZ-induced 
diabe t ic and insulin- inj ec ted STZ-induced d iabetic mice did no t have levels 
o f  morphine in their brains s ignif icantly dif f erent from each o ther , des­
p ite the fac t that the degrees of ant inoc icep tion wer e s ignif icantly low­
er and higher , than control , respec tively , in these groups of mice . This  
sugge s t s  that under certain conditions the level of  morphine in the brain 
may no t always reflect the level of ant ino c icep tion , and also  sugges t s  
that hyperglycemia ultimately exert s  a central ef fect o n  the action o f  
morphine . This central eff ec t  is appar ently selec t ive for only certain 
narco t ic analgesics . 
The experiments with STZ- induced d iabetic mice  demons trate that the 
ant ino c icep t ive potency of mQrphine can be s elec tively alter ed , without 
a f f ect ing the potency of all nar co t ics ( e . g .  methadone ) . Other inves ti­
gator s  have been able to s elec t ively af f ec t  ei ther morphine ' s  or methadone ' s  
ef f ec ts . Sprague and Takemor i  ( 19 7 8 )  have reported that pretreatment of  
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mic e  with methamphe tamine significantly increased both the antinoc icep t ive 
pot ency of oorphine and brain morphine levels .  There was a s l ight increase 
in me thadone potency and no increase in bra in me thadone levels . Ros ecrans 
and his colleagues have r epor t ed that var ious treatments will al ter the 
potency of morphine while not aff ecting the potency of me thadone . Ros ecrans 
� a1 . (1977) r epor t ed that depletion of brain dopamine s ignificantly 
a t tenuated morphine- but not methadone-induced ant inocicept ion . Chanc e 
� a 1 . (1 97 8 )  have r epor ted that les ions of the medial r aphe nucleu s  of 
r a t s  ( e f f ec tively lowering s erotonin levels in asc end ing sys tems ) antag­
onized the analgesic eff ec ts  of morphine bu t not me thadone , whereas 
lesions of the descending sys tems blocked the effects  of both drug s , sug­
ges ting dif f er ent sites of action for the two drug s . Also sugges t ive of 
a d iff erence in the act ions of morphine and me thadone is the obs ervat ion 
tha t apomorphine- ( a  dopamine recep tor s t imulant )  induc ed s t er eotypic b e­
havior is potentiated by methadone , but not morphine . Conver s ely , d­
amphe tamine- (which s t imulates r eleas e  of and blocks r eup take of norep ine­
phr ine and dopamine) induced s t ereotypic behavior is markedly potentiated 
by morphine but only s lightly so  by methadone ( John A .  Ros ecrans , personal 
communication) . 
An alternative explanat ion for d iff erenc es be tween morphine and me tha­
done has been offered by May ( 197 2 ) .  In his ar ticle reviewing a t t emp t s  t o  
conver t narcotic agonists into antagoni s t s , h e  r emarks that c er tain c l a s s e s  
o f  agonis ts have not been successfully conver ted t o  antagonis t s , and makes 
the obs erva tion that thos e drugs which have been successfully conv er t ed 
all  share a par t icular s truc tural s imilar ity ; the molecular s truc ture of 
the d rug is quite rigid . In thes e narcot ic s , twi s t ing of the groups 
a t tached to their qua ternary carbon cannot occur . Those drugs which have 
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no t been succes sfully conver ted to  antagoni s t s  d o  no t shar e this s ame 
r ig id s truc tur e .  The groups a t t ached to their quat ernary carbons c an twi s t  
t o  varying d egrees depend ing upon the bulk o f  the sub s titu t ions . 
In this disser ta tion , tho s e  analgesics who se  po tencies wer e altered by 
S TZ- induced d iabe tes all have r ig id molecular s truc tures  (morphine , levor­
phano l ,  phena zoc ine ) ,  while the po tenc ies of  methadone , propoxyphene and 
mep erid ine , which do no t have r ig id s truc tures (Figur e 5 ) , were no t alter­
ed by S TZ- induced d iabetes . Ther e is o ther evid enc e to suppor t the view 
tha t  the struc tural  r ig id i ty of  a narco t ic can a f f e c t  its  act ions . S inc e 
the d is covery o f  s t ereospec i f ic opiate-recep tor b ind ing (Per t and Snyder , 
1 9 7 3a , b )  many narco t ic agonists  and antagonis ts have been evaluated with 
respect  to  their relative aff inity for the r ec ep tor . Drugs that show high 
af f inity bind ing all have r ig id mol ecular s truc tures  (Per t  and Snyder , 
1 9 7 3 a , b ) . In contras t ,  drugs with low recep tor af f inity have non-rigid 
s truc tures . Narcotics with rigid s truc tur es are no t always mor e  p o t ent 
than those  with non-rigid s tructur e s . For example , morphine and me thadone 
are e quipo tent in produc ing ant inocicep t ion . Bind ing a f f inity may thus b e  
mor e  important for r igid than non-r igid narcot ics to  produce their e f f e c t s . 
Ano ther fac tor ( e . g . intr ins ic activity ) could b e  mor e  impor tant than b ind­
ing a f f inity for non-rigid narc o t ic s . Diabetes-induced hyperglyc emia may 
then yield ano ther per ipheral e f f ec t  that could result in a change in the 
opia t e  receptor . This might affect  the b ind ing a f f inity o f  all nar co t i c s , 
and therefore have a gr eat er e f f e c t  on the ant inocicep t ive p o t ency o f  
tho s e  narco tics  wi th r igid than non-r igid s truc tures . STZ-induc ed d ia­
b e t ic rats  have s ignif icantly elevat ed s erum levels of ACTH and cortico­
s t erone (DeNico la et al . ,  197 7 ) . ACTH can a t t enuat e  the ant ino c ic ep t ive 
p o t ency of  morphine ( Takemor i ,  1 9 7 6 )  r epor t ed ly by inhibi t ing i t s  
af f inity f o r  bind ing to the opiate receptor (Terenius , 1 9 7 5 ) . This could 
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Figure 5 
S truc tures  of the narcotic analges ics and antagonist tes ted in mice with 
altered blood glucose levels .  Thos e  drugs whos e  antinocicep tive p o t en­
cies were altered in mice with STZ-induced d iabetes or other pretreatments  
are markeQ with an as terisk ( * ) . 
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b e  the mechanism by which hyperglycemia affects  the antinocicep tive po­
t ency o f  morphine . 
�nen na loxone wa s u s ed to  antagoni ze  the ant inociceptive e f f ec t s  of  
morphine , the STZ- induced d iabetic mic e d emons tra t ed a decr eas ed s ens i t iv­
i ty t o  morphine compar ed with control  mic e , regardless o f  the d o s e  o f  
naloxone . One can sp eculate that there may be  a d ecrease in the number or 
an a l t eration in the conforma t ion of  recep tor s available to b ind to mor­
phine . The ant inocicep t ive po tenc ies o f  methadone , propoxyphene and 
meper id ine were no t altered by S TZ- induc ed d iabetes perhaps becau s e  the 
chang e in the rec ep tors that may be speculated to have occurr ed af f ec ted 
the b ind ing of  certain drug molecules ( e . g .  morphine ) which ar e too r i g id 
in s truc tur e to f i t  into the altered recep tor . It  is  widely accep ted , 
s ince having been propo s ed by Mar tin � a1 . ( 19 7 6 ) , that there are a t  
l ea s t  three d i f f er ent classes of opiate r eceptors and that two o f  the s e  
a r e  involved in ant inocicep tion . Perhap s the l e s s  r igid s truc tur es ( e . g .  
methadone) have af f inity and intr ins ic ac t ivity f or d if f er ent receptors 
than morphine inc lud ing the pos s ib ly alter ed receptors in STZ-indu c ed 
d iabe t ic mice . The specula ted change in conformation is apparently no t 
due to changes in brain glucose  levels . 
In add ition to the a t t enuated antinociceptive potency of  morphine seen 
in STZ- induced diabetic mice was the s ignif icantly po tentiated l e thal e f f ec t  
o f  morphine demons trat ed in the LDSO experiment . The physiologic a l t er a­
t ion in the STZ- induc ed d iabetic mice respons ible for morphine ' s  d ecreased 
ant inoc icep tive ef f ec t s  and increased lethality could be d i f f er ent . Neither 
the ant inoc icep tive potency nor the lethality of methadone were al ter ed by 
S TZ- induced d iabetes , provid ing fur ther suppor t for the p o s it ion that 
there is a diff erence in the ac t ions o f  morphine and methadone and a s e­
lec t ive e f f ec t  of  d iabetes  on drug potency . Dif f er ent recep tor s may a l s o  
8 9  
be involved f o r  morphine- vs . me thadone- induc ed le thality . 
There ar e repor t s  that morphine exer t s  a d irect  ef f ec t  on b lood g lu-
c o s e  levels . Intravenous and intraventricular adminis trat ion ( a t  1 / 50 the 
i . v .  dosage) of morphine produce marked hyperglycemia within 15  min which 
las ted for 60 min (Borison e t  a l . , 1 9 6 2  and 1 9 6 4 ) . The hyperglycemia they 
obs erved following morphine adminis tra t ion was no t as much a s  was achiev ed 
in this d iss er tation by STZ- induc ed d iabe tes or d extrose pretreatmen t . The 
highe s t  dosage of morphine utili zed in this d i s s er tation to produc e anti-
nocicep tion ( 8  mg / kg s . c . ) was no t su f f icient to cau s e  hyper glycemia in 
control  Swiss mic e (Table 24 ) . The hyper gly c emic e f f e c t  of intraven tr icu-
lar ly adminis tered morphine occur s concommitantly wi th a t emporary par t ial 
d ep l e t ion of  hypo thalamic catecho lamines (Moore e t  al . ,  1 9 6 5 ) . The int er-
a c t ion be tween cer tain narcotics  and glucose  metabolism is further sug-
ges t ed by repor ts tha t heroin add icts  have a delayed and a t t enua t ed hyp er-
gly cemic response af ter a g lucose  tolerance tes t , high resting insul in 
levels , and a d elayed hyp erinsulinemic respons e following the t e s t  (Reed 
and Ghod s e ,  1 9 7 3 ;  Brambilla et a l . , 19 7 6 ;  Ghod s e , 197 7 ) . Whe ther the re-
por ted " t oleranc e" to  the effects  of  gluc o s e  inges t ion in  add i c t s  has any 
d ir ec t relationship to the mor e  f amiliar toleranc e d ev elopment to her o in 
(or  t o  the decreased ant inocicep t ive potency o f  morphine repor ted in this 
d is s er tation) is  uncer tain , but intr iguing to  cons ider . Les lie  et a l . 
( 1 9 7 9 )  have even hyp o thes i zed that non-insulin-dep endent d iabetes  may b e  
d u e  t o  an inherent super- sens i t ivity to  enkephalin . However , t h e  d a t a  t o  
suppor t their hypothesis  is purely circums tantial . Levorphano l ,  l ike mor-
phine , has been repor ted to cause  marked hyperglycemia (Keith � a l . ,  1 9 5 5 ; 
P i t t inger e t  al . , 1 9 5 5 ) . In contras t ,  methadone ( I sbell e t  al . ,  1 9 4 7 ) , 
propoxyphene (Wied erho l t  e t  a l . , 1 9 6 7 ) and mep er id ine (Dey and Feldber g , 
1 9 7 5 )  who s e  ant inocicep t ive potencies wer e no t al tered by STZ-induced 
d iabe tes ar e ei ther very weakly hyp erglycemic , hypoglycemic , or have no 
ef f ec t  on BGL ' s .  
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Levine and Go ld s te in ( 1 9 5 5 )  and Bat taglia and Rand le ( 1 9 5 9 ) have r e­
por ted tha t insulin does no t have an e f f e c t  on the up take or u t i l i z a t ion 
of  f ruc tose by body t i s sues , in c ontras t  to  insulin ' s  facil itation of the 
uptake and utilization of  gluco se  and c er ta in o ther sugar s . A number o f  
t is sues in the body (peripheral nerves , erythrocy tes , lens ) do  no t r e­
quire insul in for the up take o f  glucose ( Bhagavan , 1 9 7 8 ) , and can freely 
absorb fruc tose from the blood (Levine and Go lds tein ,  1 9 5 5 ) . When hyp er­
glycemia occurs (as  in d iabetes ) these  tissues wil l  conver t the exc e s s  
glu c o s e  to  fruc tose and sorbitol i n  quantities much greater than normal ly 
occur s . The d ecreas ed sens itivity to  morphine seen in diab e t ic mice is  
no t l ikely to be due  t o  a buildup o f  f ruc tose  or s orb itol in  a key insu­
l in- ins ens itive per ipheral tissue or brain . This is b ecause  the tail­
f l ick test  detects central e f f ec ts , and wi thou t a narcotic  pr esen t , tail­
f l ick latency was no t a f f ec t ed by hyper glycemia . 
King et a l .  ( 1 9 7 7 and 1 9 7 8 )  have r epor ted that morphine has d o s e­
d ep endent ef f ec t s  on brain ener gy metabolism ,  mo s t  no tab ly d ecreas ing 
brain malate levels as morphine-induc ed ant inocicep t ion increases . Levor­
phano l ,  too , has a s ignif icant dose-dep end ent ef fec t  on malate l evels , 
wh i l e  methadone and meperidine , who s e  ant inocicep t ive po tenc ies wer e no t 
a l t er ed by STZ- induced d iabetes , had s ignif ic ant effects  on brain mala t e  
levels only at int ermed iate and n o t  high doses  ( L . J .  King , persona l  c om­
municat ion) . S ince malat e  is  a c omponent o f  the c i tr ic acid cycle , one 
could speculate that the hyperglycemia c ould a f f e c t  the cycle , increasing 
its ac t ivity and prevent ing morphine ' s  e f f ec t s . Experimentally-indu c ed 
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d iabetes  has already been shown t o  have a. myr iad of  ef f ec t s  o n  carbohydra t e  
metabolism in the brain (Prasannan and Subramanvan , 1 9 6 8 ; Flock e t  a 1 . ,  
1 9 6 9 ) . Rud e�n � a l .  ( 1 9 7 4 )  have r epor ted that STZ-induced diab e t i c  r a t s  
have signif icant ly increased concentrations of  fructose-6-phospha t e , a c e ty l  
.CoA , glycogen and c i tric ac id in their br ains c ompaired to nond iab e t i c  
ra t s .  They d id no t det ermine the l evel of  malate i n  these  brains . If  a 
decrease in malate levels of  the brain is nec essary for morphine-induced 
ant inoc icep t ion , one could speculate this  to  be  a p o s s ible site o f  inter­
a c t ion be tween diabetes and morphine ' s  e f f ec t s . 
Fo rmal r eviews of  many pharmacologic agen t s  tha t can ei ther increase 
o r  d ecrease morphine potency have b een prepared by Hans t en ( 1 9 7 1 )  and 
Takemor i  ( 1 97 6 ) . It  is no tewor thy that many of the pharmacologic agen t s  
t h a t  can alter the po tency of  morphine are drugs that a f f e c t  neuro trans­
mit ter sys t ems in  the brain (Harris e t  a1 . , 1 9 6 9 ; Dewey et  a1 . ,  1 9 6 9 ;  
Harris  et a 1 . , 1 9 6 9 ; Howes � a1 . ,  1 9 6 9 ; Dewey et a 1 . , 1 9 7 0 ; Calcu t t  e t  
a 1 . , 1 9 7 1 ; Maj o r  and P1 euvry , 1 9 7 1 ; Sparkes and Spencer , 1 9 7 1 ; Ayhan , 1 9 7 2 ; 
Cl ouet , 1 9 7 5 ;  Govoni et  a 1 . , 1 9 7 5 ; Bloom e t  a1 . , 1 9 7 6 ;  Racagni e t  a1 . , 
1 9 7 7 ;  Ro secrans � a1 . , 1 9 7 7 ; Phebu s and Lytle , 1 9 7 8 ;  S trombom and 
Svens son,  1 9 7 8 ;  E1chisak and Ro secrans , 1 9 7 9 ; Ro s ecrans e t  a1 . , 1 9 7 9 ) . 
There is  thus reason to specula t e  that if the CNS neurochemical sys t ems 
are alt ered in diabetic s , a change in morphine p o t ency may be obs erved . 
Several r epor t s  have appeared sugges t ing that several of  the conse­
quenc es of  d iabe tes affect the func t ion of  bo th the dopaminergic and 
s ero toner gic sys tems of d iabetics . Blood vessels in kidneys o f  d iabe t i c  
humans do not vasodi1ate af ter dopamine infus ion ( S chacht and Baldwin , 
1 9 7 7 ) . An unusually high p ercentage of  pat ients  in mental ins titut ions 
have d iabetes (Wait zkin , 1 9 6 6 a  and b ;  Koranyi , 1 9 7 9 ) . Many of the s e  
p a t ients , onc e diagno sed and treated f or diabetes , have had spontaneous 
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r �is s ions of  the signs and symp toms of  their mental illnesses  (Korany i , 
1 9 7 9 ) . Af f ective disorders wer e mo s t  common in the s e  pat ient s ,  sugge s t ing 
that these pat ients ' central bio genic amine sys tems were no t func t ioning 
prop er ly . 
STZ- induced diabetic rats  have lower brain tryp tophan levels than 
nond iabetics  (}�cKenzie and Trulson , 1 9 7 8 c ) . Insul in adminis tration t o  
STZ- induc ed diabetic r a t s  returned their brain tryp tophan l evels to  normal 
(}�cKen zie and Trulson , 19 7 8 a , b ,  c and e ;  Crand all and Ferns trom ,  1 9 7 9 ) . 
S e r o t onin turnover rates were norma l even in sever ely d iabetic r a t s  
(MacKenzie and Trul son , 1 9 7 8 c  and e ) . These  s ame authors ( 1 9 7 8d )  r eport­
ed tha t significantly f ewer STZ- induc ed diabetic  rats  d isp layed a b ehavior­
al syndrome ( Jacobs , 197 6 )  induc ed by p-ch1oroamphetamine and tryp tophan 
p lu s  pargyline than d id nond iabetic rats . There have been o ther r ep or t s  
that the central sero toner gic ( Fernand o and Cur z on , 197 8 )  and dopaminer gic 
(}�r shall et a l . , 197 6 ;  }�r shall , 1 9 7 8a and b ;  Har shall et  al . ,  19 7 8 )  
sys tems o f  diabetic rats  ar e resis tant t o  pharmacologic manipulation . Thus 
there is cir cums tantial evid enc e to  suppor t the speculation that alt era­
t ions of the sero toner gic and / o r  dopaminer gic sys tems in the brains o f  
S TZ- induc ed d iabetic mice could b e  par tly respons ib le for morphine ' s  de­
cr eased ant inoc icep tive potency . 
It should be no ted that species d i f f er ences in basal and intermed iary 
metabol ism and d i f f er ences be tween human diabetes  mellitus and the animal 
mod els used in this d is s ertation make i t  imp o s s ible  to assume that human 
d iabe t ics are less  s ens itive to the analgesic e f f ec t s  o f  morphine . There 
is  no such evidenc e in the l i teratur e that human d iabe t ics are less s en s i­
t iv e  to the analgesic ef fects  of  any narcotic ana lges ic , p erhaps due to  
the r igid control of  BGL ' s in diabetics exer ted by physicians dur ing 
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hospitaliza tion (Gidd ings , 1 9 7 4 ) . 
In summary , any one or a combina tion o f  the following may b e  int er­
med iary s tep s in the alterat ion o f  the ant inocicep t ive potency o f  morphine 
by STZ- induced diabetes : alterations in the conforma t ion o f  c er ta in opiate  
r ec ep tor s ; changes in  the respons ivene s s  to  morphine o f  the  neuro tr ans­
mit ter sy stems in the brain ; and alterat ions in brain ener gy me tab o l i sm as 
ind icated by changes in brain malate level s .  The data do  no t allow mor e  
than speculat ion on these ideas . However , ther e is suf f icient evid enc e t o  
hypo the size  that the principal f ac tor o f  the d iabe t ic s tate  r espons ib l e  
f o r  the altered ant inocic ep t ive potency o f  morphine i s  probab ly the pres­
enc e of  hyperglycemia . This is suppor t ed by  the experiments demons trating 
tha t r ever sal of the STZ- and d extr o s e- induc ed hyperg lycemia in mic e by 
insulin r eturned sens i t ivity to morphine ' s  ant ino c icep tive e f f e c t s  to 
normal . Blood glucose  levels but no t serum insul in levels or brain glu­
cose  levels correla ted wi th changes in the ant inoc icep tive p o t ency of 
morphine . 
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